{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:07:38Z","timestamp":1792375658881,"version":"4.4.0"},"reference-count":284,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"Abstract<\/jats:title>\n \n Purpose<\/jats:title>\n The hypothalamic\u2013pituitary\u2013adrenal (HPA) axis exerts many actions on the central nervous system (CNS) aside from stress regulation. Glucocorticoids (GCs) play an important role in affecting several cognitive functions through the effects on both glucocorticoid (GR) and mineralocorticoid receptors (MR). In this review, we aim to unravel the spectrum of cognitive dysfunction secondary to derangement of circulating levels of endogenous and exogenous glucocorticoids.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n All relevant human prospective and retrospective studies published up to 2022 in PubMed reporting information on HPA disorders, GCs, and cognition were included.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Cognitive impairment is commonly found in GC-related disorders. The main brain areas affected are the hippocampus and pre-frontal cortex, with memory being the most affected domain. Disease duration, circadian rhythm disruption, circulating GCs levels, and unbalanced MR\/GR activation are all risk factors for cognitive decline in these patients, albeit with conflicting data among different conditions. Lack of normalization of cognitive dysfunction after treatment is potentially attributable to GC-dependent structural brain alterations, which can persist even after long-term remission.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The recognition of cognitive deficits in patients with GC-related disorders is challenging, often delayed, or mistaken. Prompt recognition and treatment of underlying disease may be important to avoid a long-lasting impact on GC-sensitive areas of the brain. However, the resolution of hormonal imbalance is not always followed by complete recovery, suggesting irreversible adverse effects on the CNS, for which there are no specific treatments. Further studies are needed to find the mechanisms involved, which may eventually be targeted for treatment strategies.<\/jats:p>\n <\/jats:sec>","DOI":"10.1007\/s40618-023-02091-7","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T11:02:11Z","timestamp":1681470131000},"page":"1961-1982","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations"],"prefix":"10.1007","volume":"46","author":[{"given":"D.","family":"De Alcubierre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-5735","authenticated-orcid":false,"given":"R.","family":"Pofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"issue":"4","key":"2091_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0196-9781(98)00012-6","volume":"19","author":"K Takahashi","year":"1998","unstructured":"Takahashi K, Totsune K, Sone M, Murakami O, Satoh F, Arihara Z et al (1998) Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides 19(4):643\u2013647","journal-title":"Peptides"},{"issue":"1","key":"2091_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/07853890310017044","volume":"36","author":"SJ Claes","year":"2004","unstructured":"Claes SJ (2004) Corticotropin-releasing hormone (CRH) in psychiatry: from stress to psychopathology. Ann Med 36(1):50\u201361. https:\/\/doi.org\/10.1080\/07853890310017044","journal-title":"Ann Med"},{"key":"2091_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1196\/annals.1296.055","volume":"1018","author":"ME Keck","year":"2004","unstructured":"Keck ME, Holsboer F, Muller MB (2004) Mouse mutants for the study of corticotropin-releasing hormone receptor function: development of novel treatment strategies for mood disorders. Ann N Y Acad Sci 1018:445\u2013457. https:\/\/doi.org\/10.1196\/annals.1296.055","journal-title":"Ann N Y Acad Sci"},{"issue":"13","key":"2091_CR4","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.2174\/0929867054039008","volume":"12","author":"A Gravanis","year":"2005","unstructured":"Gravanis A, Margioris AN (2005) The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications. Curr Med Chem 12(13):1503\u20131512","journal-title":"Curr Med Chem"},{"issue":"5","key":"2091_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0196-9781(01)00384-9","volume":"22","author":"GN Smagin","year":"2001","unstructured":"Smagin GN, Heinrichs SC, Dunn AJ (2001) The role of CRH in behavioral responses to stress. Peptides 22(5):713\u2013724","journal-title":"Peptides"},{"key":"2091_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","volume":"44","author":"TL Bale","year":"2004","unstructured":"Bale TL, Vale WW (2004) CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44:525\u2013557. https:\/\/doi.org\/10.1146\/annurev.pharmtox.44.101802.121410","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"2091_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1210\/edrv-7-3-284","volume":"7","author":"RM Sapolsky","year":"1986","unstructured":"Sapolsky RM, Krey LC, McEwen BS (1986) The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7(3):284\u2013301. https:\/\/doi.org\/10.1210\/edrv-7-3-284","journal-title":"Endocr Rev"},{"issue":"7","key":"2091_CR8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/nrendo.2009.106","volume":"5","author":"GP Chrousos","year":"2009","unstructured":"Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5(7):374\u2013381. https:\/\/doi.org\/10.1038\/nrendo.2009.106","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2091_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41583-018-0088-y","volume":"20","author":"RW Logan","year":"2019","unstructured":"Logan RW, McClung CA (2019) Rhythms of life: circadian disruption and brain disorders across the lifespan. Nat Rev Neurosci 20(1):49\u201365. https:\/\/doi.org\/10.1038\/s41583-018-0088-y","journal-title":"Nat Rev Neurosci"},{"issue":"1\u20136","key":"2091_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0960-0760(93)90073-6","volume":"47","author":"ER de Kloet","year":"1993","unstructured":"de Kloet ER, Sutanto W, van den Berg DT, Carey MP, van Haarst AD, Hornsby CD et al (1993) Brain mineralocorticoid receptor diversity: functional implications. J Steroid Biochem Mol Biol 47(1\u20136):183\u2013190. https:\/\/doi.org\/10.1016\/0960-0760(93)90073-6","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"2091_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/0896-6273(88)90136-5","volume":"1","author":"JL Arriza","year":"1988","unstructured":"Arriza JL, Simerly RB, Swanson LW, Evans RM (1988) The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1(9):887\u2013900. https:\/\/doi.org\/10.1016\/0896-6273(88)90136-5","journal-title":"Neuron"},{"issue":"4","key":"2091_CR12","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1046\/j.1523-1755.2000.00971.x","volume":"57","author":"ER de Kloet","year":"2000","unstructured":"de Kloet ER, Van Acker SA, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K et al (2000) Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 57(4):1329\u20131336. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00971.x","journal-title":"Kidney Int"},{"key":"2091_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12379","author":"ER de Kloet","year":"2016","unstructured":"de Kloet ER, Otte C, Kumsta R, Kok L, Hillegers MH, Hasselmann H et al (2016) Stress and depression: a crucial role of the mineralocorticoid receptor. J Neuroendocrinol. https:\/\/doi.org\/10.1111\/jne.12379","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"2091_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bbr.2008.05.002","volume":"193","author":"JC Wingard","year":"2008","unstructured":"Wingard JC, Packard MG (2008) The amygdala and emotional modulation of competition between cognitive and habit memory. Behav Brain Res 193(1):126\u2013131. https:\/\/doi.org\/10.1016\/j.bbr.2008.05.002","journal-title":"Behav Brain Res"},{"issue":"6","key":"2091_CR15","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/npp.2016.262","volume":"42","author":"S Vogel","year":"2017","unstructured":"Vogel S, Klumpers F, Schroder TN, Oplaat KT, Krugers HJ, Oitzl MS et al (2017) Stress induces a shift towards striatum-dependent stimulus-response learning via the mineralocorticoid receptor. Neuropsychopharmacology 42(6):1262\u20131271. https:\/\/doi.org\/10.1038\/npp.2016.262","journal-title":"Neuropsychopharmacology"},{"key":"2091_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1196\/annals.1286.035","volume":"1007","author":"MC Holmes","year":"2003","unstructured":"Holmes MC, Yau JL, Kotelevtsev Y, Mullins JJ, Seckl JR (2003) 11 Beta-hydroxysteroid dehydrogenases in the brain: two enzymes two roles. Ann N Y Acad Sci 1007:357\u2013366","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2091_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3109\/14767058.2016.1171308","volume":"30","author":"P Konstantakou","year":"2017","unstructured":"Konstantakou P, Mastorakos G, Vrachnis N, Tomlinson JW, Valsamakis G (2017) Dysregulation of 11beta-hydroxysteroid dehydrogenases: implications during pregnancy and beyond. J Matern Fetal Neonatal Med 30(3):284\u2013293. https:\/\/doi.org\/10.3109\/14767058.2016.1171308","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"2091_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1210\/er.2012-1050","volume":"34","author":"LL Gathercole","year":"2013","unstructured":"Gathercole LL, Lavery GG, Morgan SA, Cooper MS, Sinclair AJ, Tomlinson JW et al (2013) 11beta-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects. Endocr Rev 34(4):525\u2013555. https:\/\/doi.org\/10.1210\/er.2012-1050","journal-title":"Endocr Rev"},{"issue":"5\u20136","key":"2091_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0960-0760(95)00195-6","volume":"55","author":"PM Stewart","year":"1995","unstructured":"Stewart PM, Whorwood CB, Mason JI (1995) Type 2 11 beta-hydroxysteroid dehydrogenase in foetal and adult life. J Steroid Biochem Mol Biol 55(5\u20136):465\u2013471","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"2091_CR20","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1210\/jc.2002-021915","volume":"88","author":"N Alfaidy","year":"2003","unstructured":"Alfaidy N, Li W, MacIntosh T, Yang K, Challis J (2003) Late gestation increase in 11beta-hydroxysteroid dehydrogenase 1 expression in human fetal membranes: a novel intrauterine source of cortisol. J Clin Endocrinol Metab 88(10):5033\u20135038. https:\/\/doi.org\/10.1210\/jc.2002-021915","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2091_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/1753495X19847832","volume":"13","author":"R Pofi","year":"2020","unstructured":"Pofi R, Tomlinson JW (2020) Glucocorticoids in pregnancy. Obstet Med 13(2):62\u201369. https:\/\/doi.org\/10.1177\/1753495X19847832","journal-title":"Obstet Med"},{"issue":"4878","key":"2091_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1126\/science.2845584","volume":"242","author":"PT Pearce","year":"1988","unstructured":"Funder JW, Pearce PT, Smith R, Smith AI (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242(4878):583\u2013585. https:\/\/doi.org\/10.1126\/science.2845584","journal-title":"Science"},{"issue":"1","key":"2091_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1523\/JNEUROSCI.16-01-00065.1996","volume":"16","author":"V Rajan","year":"1996","unstructured":"Rajan V, Edwards CR, Seckl JR (1996) 11 beta-hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J Neurosci 16(1):65\u201370","journal-title":"J Neurosci"},{"key":"2091_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.steroids.2014.08.014","volume":"91","author":"EP Gomez-Sanchez","year":"2014","unstructured":"Gomez-Sanchez EP (2014) Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis. Steroids 91:20\u201331. https:\/\/doi.org\/10.1016\/j.steroids.2014.08.014","journal-title":"Steroids"},{"issue":"3","key":"2091_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1210\/edrv.19.3.0331","volume":"19","author":"ER De Kloet","year":"1998","unstructured":"De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19(3):269\u2013301. https:\/\/doi.org\/10.1210\/edrv.19.3.0331","journal-title":"Endocr Rev"},{"issue":"1","key":"2091_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/sj.npp.1301217","volume":"32","author":"C Otte","year":"2007","unstructured":"Otte C, Moritz S, Yassouridis A, Koop M, Madrischewski AM, Wiedemann K et al (2007) Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition. Neuropsychopharmacology 32(1):232\u2013238. https:\/\/doi.org\/10.1038\/sj.npp.1301217","journal-title":"Neuropsychopharmacology"},{"key":"2091_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.nlm.2016.10.006","volume":"136","author":"D Piber","year":"2016","unstructured":"Piber D, Schultebraucks K, Mueller SC, Deuter CE, Wingenfeld K, Otte C (2016) Mineralocorticoid receptor stimulation effects on spatial memory in healthy young adults: a study using the virtual Morris Water Maze task. Neurobiol Learn Mem 136:139\u2013146. https:\/\/doi.org\/10.1016\/j.nlm.2016.10.006","journal-title":"Neurobiol Learn Mem"},{"issue":"8","key":"2091_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/s0006-3223(97)00484-8","volume":"43","author":"JF Lopez","year":"1998","unstructured":"Lopez JF, Chalmers DT, Little KY, Watson SJ, A.E. Bennett Research Award (1998) Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43(8):547\u2013573. https:\/\/doi.org\/10.1016\/s0006-3223(97)00484-8","journal-title":"Biol Psychiatry"},{"issue":"3","key":"2091_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1046\/j.1365-2826.2003.00986.x","volume":"15","author":"AH Veenema","year":"2003","unstructured":"Veenema AH, Meijer OC, de Kloet ER, Koolhaas JM (2003) Genetic selection for coping style predicts stressor susceptibility. J Neuroendocrinol 15(3):256\u2013267. https:\/\/doi.org\/10.1046\/j.1365-2826.2003.00986.x","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"2091_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biopsych.2009.03.006","volume":"66","author":"S Qin","year":"2009","unstructured":"Qin S, Hermans EJ, van Marle HJ, Luo J, Fernandez G (2009) Acute psychological stress reduces working memory-related activity in the dorsolateral prefrontal cortex. Biol Psychiatry 66(1):25\u201332. https:\/\/doi.org\/10.1016\/j.biopsych.2009.03.006","journal-title":"Biol Psychiatry"},{"issue":"5940","key":"2091_CR31","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1126\/science.1171203","volume":"325","author":"E Dias-Ferreira","year":"2009","unstructured":"Dias-Ferreira E, Sousa JC, Melo I, Morgado P, Mesquita AR, Cerqueira JJ et al (2009) Chronic stress causes frontostriatal reorganization and affects decision-making. Science 325(5940):621\u2013625. https:\/\/doi.org\/10.1126\/science.1171203","journal-title":"Science"},{"issue":"3","key":"2091_CR32","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/cphy.c130044","volume":"4","author":"E Gomez-Sanchez","year":"2014","unstructured":"Gomez-Sanchez E, Gomez-Sanchez CE (2014) The multifaceted mineralocorticoid receptor. Compr Physiol 4(3):965\u2013994. https:\/\/doi.org\/10.1002\/cphy.c130044","journal-title":"Compr Physiol"},{"key":"2091_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2147\/CLEP.S44336","volume":"7","author":"ST Sharma","year":"2015","unstructured":"Sharma ST, Nieman LK, Feelders RA (2015) Cushing\u2019s syndrome: epidemiology and developments in disease management. Clin Epidemiol 7:281\u2013293. https:\/\/doi.org\/10.2147\/CLEP.S44336","journal-title":"Clin Epidemiol"},{"issue":"8","key":"2091_CR34","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1590\/s0004-27302007000800025","volume":"51","author":"R Pivonello","year":"2007","unstructured":"Pivonello R, De Martino M, De Leo M, Tauchmanov\u00e0 L, Faggiano A, Lombardi G et al (2007) Cushing\u2019s syndrome: aftermath of the cure. Arq Bras Endocrinol Metabol 51(8):1381\u20131391. https:\/\/doi.org\/10.1590\/s0004-27302007000800025","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"2091_CR35","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EC-19-0435","volume":"9","author":"C Scaroni","year":"2020","unstructured":"Scaroni C, Albiger NM, Palmieri S, Iacuaniello D, Graziadio C, Damiani L et al (2020) Approach to patients with pseudo-Cushing\u2019s states. Endocr Connect 9(1):R1\u2013R13. https:\/\/doi.org\/10.1530\/EC-19-0435","journal-title":"Endocr Connect"},{"issue":"12","key":"2091_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2091_CR37","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/s2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BMK, Colao A (2016) Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol 4(7):611\u2013629. https:\/\/doi.org\/10.1016\/s2213-8587(16)00086-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2091_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnins.2015.00129","volume":"9","author":"R Pivonello","year":"2015","unstructured":"Pivonello R, Simeoli C, De Martino MC, Cozzolino A, De Leo M, Iacuaniello D et al (2015) Neuropsychiatric disorders in Cushing\u2019s syndrome. Front Neurosci 9:129. https:\/\/doi.org\/10.3389\/fnins.2015.00129","journal-title":"Front Neurosci"},{"issue":"1","key":"2091_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/1872214810666160809113021","volume":"10","author":"G Bernini","year":"2016","unstructured":"Bernini G, Tric\u00f2 D (2016) Cushing\u2019s syndrome and steroid dementia. Recent Pat Endocr Metab Immune Drug Discovery 10(1):50\u201355. https:\/\/doi.org\/10.2174\/1872214810666160809113021","journal-title":"Recent Pat Endocr Metab Immune Drug Discovery"},{"issue":"5","key":"2091_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2165\/00023210-200115050-00003","volume":"15","author":"N Sonino","year":"2001","unstructured":"Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing\u2019s syndrome. CNS Drugs 15(5):361\u201373. https:\/\/doi.org\/10.2165\/00023210-200115050-00003","journal-title":"CNS Drugs"},{"issue":"4","key":"2091_CR41","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10143-019-01134-z","volume":"43","author":"M Pertichetti","year":"2020","unstructured":"Pertichetti M, Serioli S, Belotti F, Mattavelli D, Schreiber A, Cappelli C et al (2020) Pituitary adenomas and neuropsychological status: a systematic literature review. Neurosurg Rev 43(4):1065\u20131078. https:\/\/doi.org\/10.1007\/s10143-019-01134-z","journal-title":"Neurosurg Rev"},{"key":"2091_CR42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jocn.2020.03.007","volume":"75","author":"L Marsh","year":"2020","unstructured":"Marsh L, Guinan E, Shah E, Powell M, Lowy C, Kopelman MD (2020) A prospective study of the cognitive and psychiatric effects of pituitary tumours and their treatments. J Clin Neurosci 75:122\u2013127. https:\/\/doi.org\/10.1016\/j.jocn.2020.03.007","journal-title":"J Clin Neurosci"},{"issue":"1","key":"2091_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/cap.2012.0037","volume":"23","author":"O Malik","year":"2013","unstructured":"Malik O, Westphal B (2013) A role for selective serotonin reuptake inhibitors in the management of residual cognitive dysfunction in pediatric Cushing\u2019s disease. J Child Adolesc Psychopharmacol 23(1):65\u201369. https:\/\/doi.org\/10.1089\/cap.2012.0037","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"2091_CR44","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/00006842-200111000-00018","volume":"63","author":"MN Starkman","year":"2001","unstructured":"Starkman MN, Giordani B, Berent S, Schork MA, Schteingart DE (2001) Elevated cortisol levels in Cushing\u2019s disease are associated with cognitive decrements. Psychosom Med. 63(6):985\u2013993. https:\/\/doi.org\/10.1097\/00006842-200111000-00018","journal-title":"Psychosom Med."},{"issue":"3","key":"2091_CR45","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ecl.2013.05.010","volume":"42","author":"MN Starkman","year":"2013","unstructured":"Starkman MN (2013) Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration. Endocrinol Metab Clin North Am 42(3):477\u2013488. https:\/\/doi.org\/10.1016\/j.ecl.2013.05.010","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"2091_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1600-0404.1993.tb04075.x","volume":"87","author":"M Mauri","year":"1993","unstructured":"Mauri M, Sinforiani E, Bono G, Vignati F, Berselli ME, Attanasio R et al (1993) Memory impairment in Cushing\u2019s disease. Acta Neurol Scand 87(1):52\u201355. https:\/\/doi.org\/10.1111\/j.1600-0404.1993.tb04075.x","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"2091_CR47","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1210\/jc.2019-00749","volume":"104","author":"KE Frimodt-Moller","year":"2019","unstructured":"Frimodt-Moller KE, Mollegaard Jepsen JR, Feldt-Rasmussen U, Krogh J (2019) Hippocampal volume, cognitive functions, depression, anxiety, and quality of life in patients with Cushing syndrome. J Clin Endocrinol Metab 104(10):4563\u20134577. https:\/\/doi.org\/10.1210\/jc.2019-00749","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2091_CR48","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1210\/jc.2011-2231","volume":"97","author":"E Resmini","year":"2012","unstructured":"Resmini E, Santos A, Gomez-Anson B, Vives Y, Pires P, Crespo I et al (2012) Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 97(2):663\u2013671. https:\/\/doi.org\/10.1210\/jc.2011-2231","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2091_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1017\/s1355617700611037","volume":"6","author":"H Forget","year":"2000","unstructured":"Forget H, Lacroix A, Somma M, Cohen H (2000) Cognitive decline in patients with Cushing\u2019s syndrome. J Int Neuropsychol Soc 6(1):20\u20139. https:\/\/doi.org\/10.1017\/s1355617700611037","journal-title":"J Int Neuropsychol Soc"},{"key":"2091_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.psyneuen.2015.11.020","volume":"65","author":"H Forget","year":"2016","unstructured":"Forget H, Lacroix A, Bourdeau I, Cohen H (2016) Long-term cognitive effects of glucocorticoid excess in Cushing\u2019s syndrome. Psychoneuroendocrinology 65:26\u201333. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.11.020","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"2091_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/archinte.1981.00340020077021","volume":"141","author":"MN Starkman","year":"1981","unstructured":"Starkman MN, Schteingart DE (1981) Neuropsychiatric manifestations of patients with Cushing\u2019s syndrome. Arch Intern Med 141(2):215\u2013219","journal-title":"Arch Intern Med"},{"issue":"1","key":"2091_CR52","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1210\/clinem\/dgaa695","volume":"106","author":"V Morelli","year":"2021","unstructured":"Morelli V, Ghielmetti A, Caldiroli A, Grassi S, Siri FM, Caletti E et al (2021) Mental health in patients with adrenal incidentalomas: Is there a relation with different degrees of cortisol secretion? J Clin Endocrinol Metab 106(1):e130\u2013e139. https:\/\/doi.org\/10.1210\/clinem\/dgaa695","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2091_CR53","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1210\/clinem\/dgac603","volume":"108","author":"MS Liu","year":"2023","unstructured":"Liu MS, Tian ZY, Zhang Z, Yang F, Lou Y, Wang YJ et al (2023) Impaired cognitive function in patients with autonomous cortisol secretion in adrenal incidentalomas. J Clin Endocrinol Metab 108(3):633\u2013641. https:\/\/doi.org\/10.1210\/clinem\/dgac603","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2091_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bandc.2009.02.013","volume":"71","author":"K Michaud","year":"2009","unstructured":"Michaud K, Forget H, Cohen H (2009) Chronic glucocorticoid hypersecretion in Cushing\u2019s syndrome exacerbates cognitive aging. Brain Cogn 71(1):1\u20138. https:\/\/doi.org\/10.1016\/j.bandc.2009.02.013","journal-title":"Brain Cogn"},{"issue":"8","key":"2091_CR55","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/wnl.56.8.1094","volume":"56","author":"ER Peskind","year":"2001","unstructured":"Peskind ER, Wilkinson CW, Petrie EC, Schellenberg GD, Raskind MA (2001) Increased CSF cortisol in AD is a function of APOE genotype. Neurology 56(8):1094\u20131098. https:\/\/doi.org\/10.1212\/wnl.56.8.1094","journal-title":"Neurology"},{"issue":"5","key":"2091_CR56","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.mehy.2008.05.036","volume":"71","author":"S Guldiken","year":"2008","unstructured":"Guldiken S, Guldiken B (2008) Subclinical Cushing\u2019s syndrome is a potential cause of metabolic dementia and rapidly progressive Alzheimer-type dementia. Med Hypotheses 71(5):703\u2013705. https:\/\/doi.org\/10.1016\/j.mehy.2008.05.036","journal-title":"Med Hypotheses"},{"issue":"1","key":"2091_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/hmg\/ddg361","volume":"13","author":"DJ de Quervain","year":"2004","unstructured":"de Quervain DJ, Poirier R, Wollmer MA, Grimaldi LM, Tsolaki M, Streffer JR et al (2004) Glucocorticoid-related genetic susceptibility for Alzheimer\u2019s disease. Hum Mol Genet 13(1):47\u201352. https:\/\/doi.org\/10.1093\/hmg\/ddg361","journal-title":"Hum Mol Genet"},{"issue":"9","key":"2091_CR58","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-f","volume":"32","author":"MN Starkman","year":"1992","unstructured":"Starkman MN, Gebarski SS, Berent S, Schteingart DE (1992) Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing\u2019s syndrome. Biol Psychiatry 32(9):756\u2013765. https:\/\/doi.org\/10.1016\/0006-3223(92)90079-f","journal-title":"Biol Psychiatry"},{"issue":"3","key":"2091_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/foc-07\/09\/e11","volume":"23","author":"CG Patil","year":"2007","unstructured":"Patil CG, Lad SP, Katznelson L, Laws ER (2007) Brain atrophy and cognitive deficits in Cushing\u2019s disease. Neurosurg Focus 23(3):1\u20134. https:\/\/doi.org\/10.3171\/foc-07\/09\/e11","journal-title":"Neurosurg Focus"},{"issue":"1","key":"2091_CR60","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-14-1101","volume":"173","author":"CD Andela","year":"2015","unstructured":"Andela CD, van Haalen FM, Ragnarsson O, Papakokkinou E, Johannsson G, Santos A et al (2015) Mechanisms in endocrinology: Cushing\u2019s syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies. Eur J Endocrinol 173(1):R1-14. https:\/\/doi.org\/10.1530\/EJE-14-1101","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2091_CR61","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/MED.0000000000000414","volume":"25","author":"S Bauduin","year":"2018","unstructured":"Bauduin S, van der Wee NJA, van der Werff SJA (2018) Structural brain abnormalities in Cushing\u2019s syndrome. Curr Opin Endocrinol Diabetes Obes 25(4):285\u2013289. https:\/\/doi.org\/10.1097\/MED.0000000000000414","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"2091_CR62","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1210\/jcem.87.5.8493","volume":"87","author":"I Bourdeau","year":"2002","unstructured":"Bourdeau I, Bard C, Bernard N, Leclerc I, Cordeau M, Be\u2019 Lair M et al (2002) Loss of brain volume in endogenous Cushing\u2019s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 87(5):1949\u20131954. https:\/\/doi.org\/10.1210\/jcem.87.5.8493","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2091_CR63","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ecl.2005.01.016","volume":"34","author":"I Bourdeau","year":"2005","unstructured":"Bourdeau I, Bard C, Forget H, Boulanger Y, Cohen H, Lacroix A (2005) Cognitive function and cerebral assessment in patients who have Cushing\u2019s syndrome. Endocrinol Metab Clin North Am 34(2):357\u2013369. https:\/\/doi.org\/10.1016\/j.ecl.2005.01.016. (ix)","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"2091_CR64","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1530\/EJE-14-0371","volume":"171","author":"A Santos","year":"2014","unstructured":"Santos A, Resmini E, Crespo I, Pires P, Vives-Gilabert Y, Granell E et al (2014) Small cerebellar cortex volume in patients with active Cushing\u2019s syndrome. Eur J Endocrinol 171(4):461\u2013469. https:\/\/doi.org\/10.1530\/EJE-14-0371","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2091_CR65","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/cen.13381","volume":"87","author":"H Jiang","year":"2017","unstructured":"Jiang H, Ren J, He N-Y, Liu C, Sun Y-H, Jian F-F et al (2017) Volumetric magnetic resonance imaging analysis in patients with short-term remission of Cushing\u2019s disease. Clin Endocrinol 87(4):367\u2013374. https:\/\/doi.org\/10.1111\/cen.13381","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2091_CR66","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/cne.21071","volume":"498","author":"DA Tata","year":"2006","unstructured":"Tata DA, Marciano VA, Anderson BJ (2006) Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3. J Comp Neurol 498(3):363\u2013374. https:\/\/doi.org\/10.1002\/cne.21071","journal-title":"J Comp Neurol"},{"key":"2091_CR67","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz303","author":"A Tirosh","year":"2020","unstructured":"Tirosh A, RaviPrakash H, Papadakis GZ, Tatsi C, Belyavskaya E, Charalampos L et al (2020) Computerized analysis of brain MRI parameter dynamics in young patients with Cushing syndrome-a case-control study. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgz303","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2091_CR68","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3174\/ajnr.A4322","volume":"36","author":"P Pires","year":"2015","unstructured":"Pires P, Santos A, Vives-Gilabert Y, Webb SM, Sainz-Ruiz A, Resmini E et al (2015) White matter alterations in the brains of patients with active, remitted, and cured Cushing syndrome: a DTI study. AJNR Am J Neuroradiol 36(6):1043\u20131048. https:\/\/doi.org\/10.3174\/ajnr.A4322","journal-title":"AJNR Am J Neuroradiol"},{"key":"2091_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2021.102770","volume":"31","author":"M Cui","year":"2021","unstructured":"Cui M, Zhou T, Feng S, Liu X, Wang F, Zhang Y et al (2021) Altered microstructural pattern of white matter in Cushing\u2019s disease identified by automated fiber quantification. Neuroimage Clin 31:102770. https:\/\/doi.org\/10.1016\/j.nicl.2021.102770","journal-title":"Neuroimage Clin"},{"issue":"3","key":"2091_CR70","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11102-017-0793-y","volume":"20","author":"P Pires","year":"2017","unstructured":"Pires P, Santos A, Vives-Gilabert Y, Webb SM, Sainz-Ruiz A, Resmini E et al (2017) White matter involvement on DTI-MRI in Cushing\u2019s syndrome relates to mood disturbances and processing speed: a case-control study. Pituitary 20(3):340\u2013348. https:\/\/doi.org\/10.1007\/s11102-017-0793-y","journal-title":"Pituitary"},{"key":"2091_CR71","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.brainres.2017.04.007","volume":"1665","author":"H Jiang","year":"2017","unstructured":"Jiang H, He NY, Sun YH, Jian FF, Bian LG, Shen JK et al (2017) Altered gray and white matter microstructure in Cushing\u2019s disease: A diffusional kurtosis imaging study. Brain Res 1665:80\u201387. https:\/\/doi.org\/10.1016\/j.brainres.2017.04.007","journal-title":"Brain Res"},{"issue":"1","key":"2091_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/eb-2017-102820","volume":"21","author":"A Topiwala","year":"2018","unstructured":"Topiwala A, Ebmeier KP (2018) Effects of drinking on late-life brain and cognition. Evid Based Ment Health 21(1):12\u201315. https:\/\/doi.org\/10.1136\/eb-2017-102820","journal-title":"Evid Based Ment Health"},{"issue":"2","key":"2091_CR73","first-page":"146","volume":"27","author":"M Rosenbloom","year":"2003","unstructured":"Rosenbloom M, Sullivan EV, Pfefferbaum A (2003) Using magnetic resonance imaging and diffusion tensor imaging to assess brain damage in alcoholics. Alcohol Res Health 27(2):146\u2013152","journal-title":"Alcohol Res Health"},{"issue":"13","key":"2091_CR74","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1017\/S0033291717000721","volume":"47","author":"S Wilson","year":"2017","unstructured":"Wilson S, Bair JL, Thomas KM, Iacono WG (2017) Problematic alcohol use and reduced hippocampal volume: a meta-analytic review. Psychol Med 47(13):2288\u20132301. https:\/\/doi.org\/10.1017\/S0033291717000721","journal-title":"Psychol Med"},{"issue":"4","key":"2091_CR75","first-page":"468","volume":"34","author":"MA Stephens","year":"2012","unstructured":"Stephens MA, Wand G (2012) Stress and the HPA axis: role of glucocorticoids in alcohol dependence. Alcohol Res 34(4):468\u2013483","journal-title":"Alcohol Res"},{"issue":"10","key":"2091_CR76","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1017\/S0033291713002535","volume":"44","author":"PL Rock","year":"2014","unstructured":"Rock PL, Roiser JP, Riedel WJ, Blackwell AD (2014) Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med 44(10):2029\u20132040. https:\/\/doi.org\/10.1017\/S0033291713002535","journal-title":"Psychol Med"},{"key":"2091_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113410","volume":"412","author":"GMJ Sousa","year":"2021","unstructured":"Sousa GMJ, Vargas HDQ, Barbosa FF, Galvao-Coelho NL (2021) Stress, memory, and implications for major depression. Behav Brain Res 412:113410. https:\/\/doi.org\/10.1016\/j.bbr.2021.113410","journal-title":"Behav Brain Res"},{"issue":"3","key":"2091_CR78","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/erv.2796","volume":"29","author":"SD Hemmingsen","year":"2021","unstructured":"Hemmingsen SD, Wesselhoeft R, Lichtenstein MB, Sjogren JM, Stoving RK (2021) Cognitive improvement following weight gain in patients with anorexia nervosa: a systematic review. Eur Eat Disord Rev 29(3):402\u2013426. https:\/\/doi.org\/10.1002\/erv.2796","journal-title":"Eur Eat Disord Rev"},{"issue":"12","key":"2091_CR79","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/17512433.2020.1850256","volume":"13","author":"J Keeler","year":"2020","unstructured":"Keeler J, Patsalos O, Thuret S, Ehrlich S, Tchanturia K, Himmerich H et al (2020) Hippocampal volume, function, and related molecular activity in anorexia nervosa: a scoping review. Expert Rev Clin Pharmacol 13(12):1367\u20131387. https:\/\/doi.org\/10.1080\/17512433.2020.1850256","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2091_CR80","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.neubiorev.2016.09.032","volume":"71","author":"S Gaudio","year":"2016","unstructured":"Gaudio S, Wiemerslage L, Brooks SJ, Schioth HB (2016) A systematic review of resting-state functional-MRI studies in anorexia nervosa: evidence for functional connectivity impairment in cognitive control and visuospatial and body-signal integration. Neurosci Biobehav Rev 71:578\u2013589. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.09.032","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"2091_CR81","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s12020-016-1083-6","volume":"54","author":"E Resmini","year":"2016","unstructured":"Resmini E, Santos A, Aulinas A, Webb SM, Vives-Gilabert Y, Cox O et al (2016) Reduced DNA methylation of FKBP5 in Cushing\u2019s syndrome. Endocrine 54(3):768\u2013777. https:\/\/doi.org\/10.1007\/s12020-016-1083-6","journal-title":"Endocrine"},{"issue":"1","key":"2091_CR82","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0033-3182(85)72906-4","volume":"26","author":"KG Kramlinger","year":"1985","unstructured":"Kramlinger KG, Peterson GC, Watson PK, Leonard LL (1985) Metyrapone for depression and delirium secondary to Cushing\u2019s syndrome. Psychosomatics 26(1):67\u201371. https:\/\/doi.org\/10.1016\/s0033-3182(85)72906-4","journal-title":"Psychosomatics"},{"issue":"6","key":"2091_CR83","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1210\/jc.2011-3350","volume":"97","author":"M Fleseriu","year":"2012","unstructured":"Fleseriu M, Biller BM, Findling JW, Molitch ME, Schteingart DE, Gross C et al (2012) Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 97(6):2039\u20132049. https:\/\/doi.org\/10.1210\/jc.2011-3350","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2091_CR84","doi-asserted-by":"publisher","first-page":"143","DOI":"10.7326\/0003-4819-114-2-143","volume":"114","author":"AJ van der Lely","year":"1991","unstructured":"van der Lely AJ, Foeken K, van der Mast RC, Lamberts SWJ (1991) Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486). Ann Intern Med 114(2):143\u2013144. https:\/\/doi.org\/10.7326\/0003-4819-114-2-143","journal-title":"Ann Intern Med"},{"issue":"3","key":"2091_CR85","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1210\/jcem.82.3.3834","volume":"82","author":"LD Dorn","year":"1997","unstructured":"Dorn LD, Burgess ES, Firedman TC, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing\u2019s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82(3):912\u2013919. https:\/\/doi.org\/10.1210\/jcem.82.3.3834","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2091_CR86","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1046\/j.1365-2265.1996.8690878.x","volume":"45","author":"WF Kelly","year":"1996","unstructured":"Kelly WF, Kelly MJ, Faragher B (1996) A prospective study of psychiatric and psychological aspects of Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 45(6):715\u2013720. https:\/\/doi.org\/10.1046\/j.1365-2265.1996.8690878.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2091_CR87","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0165-1781(86)90096-x","volume":"19","author":"MN Starkman","year":"1986","unstructured":"Starkman MN, Schteingart DE, Schork MA (1986) Cushing\u2019s syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome. Psychiatry Res 19(3):177\u2013188. https:\/\/doi.org\/10.1016\/0165-1781(86)90096-x","journal-title":"Psychiatry Res"},{"issue":"1","key":"2091_CR88","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1017\/S1355617707070051","volume":"13","author":"JN Hook","year":"2007","unstructured":"Hook JN, Giordani B, Schteingart DE, Guire K, Giles J, Kelley R et al (2007) Patterns of cognitive change over time and relationship to age following successful treatment of Cushing\u2019s disease. J Int Neuropsychol Soc 13(1):21\u201329. https:\/\/doi.org\/10.1017\/S1355617707070051","journal-title":"J Int Neuropsychol Soc"},{"issue":"12","key":"2091_CR89","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ncpendmet0344","volume":"2","author":"LL Levitsky","year":"2006","unstructured":"Levitsky LL (2006) Cognitive dysfunction following treatment of Cushing\u2019s syndrome. Nat Clin Pract Endocrinol Metab 2(12):666\u2013667. https:\/\/doi.org\/10.1038\/ncpendmet0344","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2091_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.934347","volume":"13","author":"E Pupier","year":"2022","unstructured":"Pupier E, Santos A, Etchamendy N, Lavielle A, Ferriere A, Marighetto A et al (2022) Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing\u2019s disease in remission. Front Endocrinol (Lausanne) 13:934347. https:\/\/doi.org\/10.3389\/fendo.2022.934347","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2091_CR91","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s0306-4530(01)00059-2","volume":"27","author":"H Forget","year":"2002","unstructured":"Forget H, Lacroix A, Cohen H (2002) Persistent cognitive impairment following surgical treatment of Cushing\u2019s syndrome. Psychoneuroendocrinology 27(3):367\u201383. https:\/\/doi.org\/10.1016\/s0306-4530(01)00059-2","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"2091_CR92","doi-asserted-by":"publisher","first-page":"E1640","DOI":"10.1210\/jc.2012-1945","volume":"97","author":"O Ragnarsson","year":"2012","unstructured":"Ragnarsson O, Berglund P, Eder DN, Johannsson G (2012) Long-term cognitive impairments and attentional deficits in patients with Cushing\u2019s disease and cortisol-producing adrenal adenoma in remission. J Clin Endocrinol Metab 97(9):E1640\u2013E1648. https:\/\/doi.org\/10.1210\/jc.2012-1945","journal-title":"J Clin Endocrinol Metab"},{"key":"2091_CR93","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/173653","volume":"2015","author":"E Papakokkinou","year":"2015","unstructured":"Papakokkinou E, Johansson B, Berglund P, Ragnarsson O (2015) Mental fatigue and executive dysfunction in patients with Cushing\u2019s syndrome in remission. Behav Neurol 2015:173653. https:\/\/doi.org\/10.1155\/2015\/173653","journal-title":"Behav Neurol"},{"issue":"9","key":"2091_CR94","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1055\/s-2006-924332","volume":"114","author":"A Heald","year":"2006","unstructured":"Heald A, Parr C, Gibson C, O\u2019Driscoll K, Fowler H (2006) A cross-sectional study to investigate long-term cognitive function in people with treated pituitary Cushing\u2019s disease. Exp Clin Endocrinol Diabetes 114(9):490\u2013497. https:\/\/doi.org\/10.1055\/s-2006-924332","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"12","key":"2091_CR95","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/s0006-3223(99)00203-6","volume":"46","author":"MN Starkman","year":"1999","unstructured":"Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE (1999) Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing\u2019s disease. Soc Biol Psychiatry 46(12):1595\u20131602. https:\/\/doi.org\/10.1016\/s0006-3223(99)00203-6","journal-title":"Soc Biol Psychiatry"},{"key":"2091_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-3223(02)01750-X","author":"MN Starkman","year":"2003","unstructured":"Starkman MN, Giordani B, Gebarski SS, Schteingart DE (2003) Improvement in learning associated with increase in hippocampal formation volume. Soc Biol Psychiatry. https:\/\/doi.org\/10.1016\/S0002-3223(02)01750-X","journal-title":"Soc Biol Psychiatry"},{"issue":"1","key":"2091_CR97","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41398-022-02249-6","volume":"12","author":"MJ Colwell","year":"2022","unstructured":"Colwell MJ, Tagomori H, Chapman S, Gillespie AL, Cowen PJ, Harmer CJ et al (2022) Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research. Transl Psychiatry 12(1):484. https:\/\/doi.org\/10.1038\/s41398-022-02249-6","journal-title":"Transl Psychiatry"},{"issue":"6","key":"2091_CR98","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/cen.12564","volume":"81","author":"I Crespo","year":"2014","unstructured":"Crespo I, Esther GM, Santos A, Valassi E, Yolanda VG, De Juan-Delago M et al (2014) Impaired decision-making and selective cortical frontal thinning in Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 81(6):826\u2013833. https:\/\/doi.org\/10.1111\/cen.12564","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2091_CR99","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1530\/EJE-13-0471","volume":"169","author":"CD Andela","year":"2013","unstructured":"Andela CD, van der Werff SJ, Pannekoek JN, van den Berg SM, Meijer OC, van Buchem MA et al (2013) Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing\u2019s disease: a case-control study. Eur J Endocrinol 169(6):811\u2013819. https:\/\/doi.org\/10.1530\/EJE-13-0471","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2091_CR100","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41398-020-00980-6","volume":"10","author":"S Bauduin","year":"2020","unstructured":"Bauduin S, van der Pal Z, Pereira AM, Meijer OC, Giltay EJ, van der Wee NJA et al (2020) Cortical thickness abnormalities in long-term remitted Cushing\u2019s disease. Transl Psychiatry 10(1):293. https:\/\/doi.org\/10.1038\/s41398-020-00980-6","journal-title":"Transl Psychiatry"},{"key":"2091_CR101","doi-asserted-by":"publisher","DOI":"10.3171\/2019.10.JNS191400","author":"B Hou","year":"2020","unstructured":"Hou B, Gao L, Shi L, Luo Y, Guo X, Young GS et al (2020) Reversibility of impaired brain structures after transsphenoidal surgery in Cushing\u2019s disease: a longitudinal study based on an artificial intelligence-assisted tool. J Neurosurg. https:\/\/doi.org\/10.3171\/2019.10.JNS191400","journal-title":"J Neurosurg"},{"issue":"5","key":"2091_CR102","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/cen.12224","volume":"79","author":"E Resmini","year":"2013","unstructured":"Resmini E, Santos A, Gomez-Anson B, Lopez-Mourelo O, Pires P, Vives-Gilabert Y et al (2013) Hippocampal dysfunction in cured Cushing\u2019s syndrome patients, detected by (1) H-MR-spectroscopy. Clin Endocrinol (Oxf) 79(5):700\u2013707. https:\/\/doi.org\/10.1111\/cen.12224","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2091_CR103","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD et al (2016) Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(2):364\u2013389. https:\/\/doi.org\/10.1210\/jc.2015-1710","journal-title":"J Clin Endocrinol Metab"},{"key":"2091_CR104","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz055","author":"R Pofi","year":"2020","unstructured":"Pofi R, Prete A, Thornton-Jones V, Bryce J, Ali SR, Faisal Ahmed S et al (2020) Plasma renin measurements are unrelated to mineralocorticoid replacement dose in patients with primary adrenal insufficiency. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgz055","journal-title":"J Clin Endocrinol Metab"},{"issue":"10274","key":"2091_CR105","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","volume":"397","author":"ES Husebye","year":"2021","unstructured":"Husebye ES, Pearce SH, Krone NP, Kampe O (2021) Adrenal insufficiency. Lancet 397(10274):613\u2013629. https:\/\/doi.org\/10.1016\/S0140-6736(21)00136-7","journal-title":"Lancet"},{"issue":"3","key":"2091_CR106","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2265.2009.03596.x","volume":"72","author":"B Bleicken","year":"2010","unstructured":"Bleicken B, Hahner S, Loeffler M, Ventz M, Decker O, Allolio B et al (2010) Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 72(3):297\u2013304. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03596.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2091_CR107","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-2826.2006.01429.x","volume":"18","author":"J Herbert","year":"2006","unstructured":"Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL et al (2006) Do corticosteroids damage the brain? J Neuroendocrinol 18(6):393\u2013411. https:\/\/doi.org\/10.1111\/j.1365-2826.2006.01429.x","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"2091_CR108","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","volume":"6","author":"AM Isidori","year":"2018","unstructured":"Isidori AM, Venneri MA, Graziadio C, Simeoli C, Fiore D, Hasenmajer V et al (2018) Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. Lancet Diabetes Endocrinol 6(3):173\u2013185. https:\/\/doi.org\/10.1016\/S2213-8587(17)30398-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2091_CR109","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/MAJ.0b013e3181db6b7a","volume":"339","author":"B Bleicken","year":"2010","unstructured":"Bleicken B, Hahner S, Ventz M, Quinkler M (2010) Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. Am J Med Sci 339(6):525\u2013531. https:\/\/doi.org\/10.1097\/MAJ.0b013e3181db6b7a","journal-title":"Am J Med Sci"},{"issue":"1","key":"2091_CR110","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0033-3182(90)72226-8","volume":"31","author":"PA Johnstone","year":"1990","unstructured":"Johnstone PA, Rundell JR, Esposito M (1990) Mental status changes of Addison\u2019s disease. Psychosomatics 31(1):103\u2013107. https:\/\/doi.org\/10.1016\/S0033-3182(90)72226-8","journal-title":"Psychosomatics"},{"issue":"2","key":"2091_CR111","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11011-014-9511-x","volume":"29","author":"M Henry","year":"2014","unstructured":"Henry M, Thomas KG, Ross IL (2014) Episodic memory impairment in Addison\u2019s disease: results from a telephonic cognitive assessment. Metab Brain Dis 29(2):421\u2013430. https:\/\/doi.org\/10.1007\/s11011-014-9511-x","journal-title":"Metab Brain Dis"},{"issue":"2","key":"2091_CR112","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1530\/EJE-14-0023","volume":"171","author":"J Tiemensma","year":"2014","unstructured":"Tiemensma J, Andela CD, Kaptein AA, Romijn JA, van der Mast RC, Biermasz NR et al (2014) Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature. Eur J Endocrinol 171(2):171\u2013182. https:\/\/doi.org\/10.1530\/EJE-14-0023","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2091_CR113","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/s0306-4530(03)00103-3","volume":"29","author":"MY Tytherleigh","year":"2004","unstructured":"Tytherleigh MY, Vedhara K, Lightman SL (2004) Mineralocorticoid and glucocorticoid receptors and their differential effects on memory performance in people with Addison\u2019s disease. Psychoneuroendocrinology 29(6):712\u2013723. https:\/\/doi.org\/10.1016\/s0306-4530(03)00103-3","journal-title":"Psychoneuroendocrinology"},{"key":"2091_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2015.01.025","volume":"55","author":"K Schultebraucks","year":"2015","unstructured":"Schultebraucks K, Wingenfeld K, Heimes J, Quinkler M, Otte C (2015) Cognitive function in patients with primary adrenal insufficiency (Addison\u2019s disease). Psychoneuroendocrinology 55:1\u20137. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.01.025","journal-title":"Psychoneuroendocrinology"},{"key":"2091_CR115","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.psyneuen.2015.09.029","volume":"63","author":"J Tiemensma","year":"2016","unstructured":"Tiemensma J, Andela CD, Biermasz NR, Romijn JA, Pereira AM (2016) Mild cognitive deficits in patients with primary adrenal insufficiency. Psychoneuroendocrinology 63:170\u2013177. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.09.029","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"2091_CR116","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.metabol.2009.06.015","volume":"58","author":"J Klement","year":"2009","unstructured":"Klement J, Hubold C, Hallschmid M, Loeck C, Oltmanns KM, Lehnert H et al (2009) Effects of glucose infusion on neuroendocrine and cognitive parameters in Addison disease. Metabolism 58(12):1825\u20131831. https:\/\/doi.org\/10.1016\/j.metabol.2009.06.015","journal-title":"Metabolism"},{"issue":"2","key":"2091_CR117","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10484-009-9082-5","volume":"34","author":"B Harbeck","year":"2009","unstructured":"Harbeck B, Kropp P, Monig H (2009) Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study. Appl Psychophysiol Biofeedback 34(2):113\u2013119. https:\/\/doi.org\/10.1007\/s10484-009-9082-5","journal-title":"Appl Psychophysiol Biofeedback"},{"issue":"8","key":"2091_CR118","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.psyneuen.2005.03.005","volume":"30","author":"S Het","year":"2005","unstructured":"Het S, Ramlow G, Wolf OT (2005) A meta-analytic review of the effects of acute cortisol administration on human memory. Psychoneuroendocrinology 30(8):771\u2013784. https:\/\/doi.org\/10.1016\/j.psyneuen.2005.03.005","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"2091_CR119","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1210\/jcem.87.8.8760","volume":"87","author":"SJ Lupien","year":"2002","unstructured":"Lupien SJ, Wilkinson CW, Briere S, Ng Ying Kin NM, Meaney MJ, Nair NP (2002) Acute modulation of aged human memory by pharmacological manipulation of glucocorticoids. J Clin Endocrinol Metab 87(8):3798\u20133807. https:\/\/doi.org\/10.1210\/jcem.87.8.8760","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2091_CR120","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/JOE-20-0066","volume":"246","author":"M Minnetti","year":"2020","unstructured":"Minnetti M, Hasenmajer V, Pofi R, Venneri MA, Alexandraki KI, Isidori AM (2020) Fixing the broken clock in adrenal disorders: focus on glucocorticoids and chronotherapy. J Endocrinol 246(2):R13\u2013R31. https:\/\/doi.org\/10.1530\/JOE-20-0066","journal-title":"J Endocrinol"},{"issue":"10","key":"2091_CR121","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/s0166-2236(99)01438-1","volume":"22","author":"ER de Kloet","year":"1999","unstructured":"de Kloet ER, Oitzl MS, Joels M (1999) Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci 22(10):422\u2013426. https:\/\/doi.org\/10.1016\/s0166-2236(99)01438-1","journal-title":"Trends Neurosci"},{"key":"2091_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.694046","volume":"12","author":"M Henry","year":"2021","unstructured":"Henry M, Thomas KGF, Ross IL (2021) Sleep, cognition and cortisol in addison\u2019s disease: a mechanistic relationship. Front Endocrinol (Lausanne) 12:694046. https:\/\/doi.org\/10.3389\/fendo.2021.694046","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2091_CR123","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0306-4530(03)00103-3","volume":"29","author":"MY Tytherleigh","year":"2004","unstructured":"Tytherleigh MY, Vedhara K, Lightman SL (2004) Mineralocorticoid and glucocorticoid receptors and their differential effects on memory performance in people with Addison\u2019s disease. Psychoneuroendocrinology 29(6):712\u2013723. https:\/\/doi.org\/10.1016\/S0306-4530(03)00103-3","journal-title":"Psychoneuroendocrinology"},{"issue":"3\u20134","key":"2091_CR124","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000438791","volume":"103","author":"K Schultebraucks","year":"2016","unstructured":"Schultebraucks K, Wingenfeld K, Otte C, Quinkler M (2016) The role of fludrocortisone in cognition and mood in patients with primary adrenal insufficiency (Addison\u2019s disease). Neuroendocrinology 103(3\u20134):315\u2013320. https:\/\/doi.org\/10.1159\/000438791","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2091_CR125","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/npp.2014.181","volume":"40","author":"C Otte","year":"2015","unstructured":"Otte C, Wingenfeld K, Kuehl LK, Kaczmarczyk M, Richter S, Quante A et al (2015) Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals. Neuropsychopharmacology 40(2):386\u2013393. https:\/\/doi.org\/10.1038\/npp.2014.181","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"2091_CR126","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.neurobiolaging.2014.09.008","volume":"36","author":"K Hinkelmann","year":"2015","unstructured":"Hinkelmann K, Wingenfeld K, Kuehl LK, Fleischer J, Heuser I, Wiedemann K et al (2015) Stimulation of the mineralocorticoid receptor improves memory in young and elderly healthy individuals. Neurobiol Aging 36(2):919\u2013924. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.09.008","journal-title":"Neurobiol Aging"},{"key":"2091_CR127","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.nlm.2015.02.013","volume":"120","author":"K Wingenfeld","year":"2015","unstructured":"Wingenfeld K, Kuehl LK, Janke K, Hinkelmann K, Eckert FC, Roepke S et al (2015) Effects of mineralocorticoid receptor stimulation via fludrocortisone on memory in women with borderline personality disorder. Neurobiol Learn Mem 120:94\u2013100. https:\/\/doi.org\/10.1016\/j.nlm.2015.02.013","journal-title":"Neurobiol Learn Mem"},{"key":"2091_CR128","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jpsychires.2015.08.001","volume":"69","author":"C Otte","year":"2015","unstructured":"Otte C, Wingenfeld K, Kuehl LK, Richter S, Regen F, Piber D et al (2015) Cognitive function in older adults with major depression: effects of mineralocorticoid receptor stimulation. J Psychiatr Res 69:120\u2013125. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.08.001","journal-title":"J Psychiatr Res"},{"issue":"6","key":"2091_CR129","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn849","volume":"3","author":"JJ Kim","year":"2002","unstructured":"Kim JJ, Diamond DM (2002) The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci 3(6):453\u2013462. https:\/\/doi.org\/10.1038\/nrn849","journal-title":"Nat Rev Neurosci"},{"key":"2091_CR130","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fnhum.2013.00123","volume":"7","author":"RM Shansky","year":"2013","unstructured":"Shansky RM, Lipps J (2013) Stress-induced cognitive dysfunction: hormone-neurotransmitter interactions in the prefrontal cortex. Front Hum Neurosci 7:123. https:\/\/doi.org\/10.3389\/fnhum.2013.00123","journal-title":"Front Hum Neurosci"},{"issue":"8","key":"2091_CR131","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1523\/JNEUROSCI.06-08-02240.1986","volume":"6","author":"RM Sapolsky","year":"1986","unstructured":"Sapolsky RM (1986) Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J Neurosci 6(8):2240\u20132244","journal-title":"J Neurosci"},{"issue":"6","key":"2091_CR132","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrn2648","volume":"10","author":"AF Arnsten","year":"2009","unstructured":"Arnsten AF (2009) Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci 10(6):410\u2013422. https:\/\/doi.org\/10.1038\/nrn2648","journal-title":"Nat Rev Neurosci"},{"key":"2091_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2020.108788","volume":"167","author":"AK Blacha","year":"2021","unstructured":"Blacha AK, Rahvar AH, Flitsch J, van de Loo I, Kropp P, Harbeck B (2021) Impaired attention in patients with adrenal insufficiency\u2014Impact of unphysiological therapy. Steroids 167:108788. https:\/\/doi.org\/10.1016\/j.steroids.2020.108788","journal-title":"Steroids"},{"issue":"3","key":"2091_CR134","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10484-016-9338-9","volume":"41","author":"B Harbeck","year":"2016","unstructured":"Harbeck B, Danneberg S, Rahvar AH, Haas CS, Lehnert H, Kropp P et al (2016) Exploring the impact of short- and long-term hydrocortisone replacement on cognitive function, quality of life and catecholamine secretion: a pilot study. Appl Psychophysiol Biofeedback 41(3):341\u2013347. https:\/\/doi.org\/10.1007\/s10484-016-9338-9","journal-title":"Appl Psychophysiol Biofeedback"},{"issue":"4","key":"2091_CR135","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1530\/eje.0.1480449","volume":"148","author":"K Lovas","year":"2003","unstructured":"Lovas K, Husebye ES, Holsten F, Bjorvatn B (2003) Sleep disturbances in patients with Addison\u2019s disease. Eur J Endocrinol 148(4):449\u2013456. https:\/\/doi.org\/10.1530\/eje.0.1480449","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2091_CR136","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000122289","volume":"15","author":"JC Gillin","year":"1974","unstructured":"Gillin JC, Jacobs LS, Snyder F, Henkin RI (1974) Effects of ACTH on the sleep of normal subjects and patients with Addison\u2019s disease. Neuroendocrinology 15(1):21\u201331. https:\/\/doi.org\/10.1159\/000122289","journal-title":"Neuroendocrinology"},{"issue":"12","key":"2091_CR137","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.biopsych.2006.03.051","volume":"60","author":"J Backhaus","year":"2006","unstructured":"Backhaus J, Junghanns K, Born J, Hohaus K, Faasch F, Hohagen F (2006) Impaired declarative memory consolidation during sleep in patients with primary insomnia: Influence of sleep architecture and nocturnal cortisol release. Biol Psychiatry 60(12):1324\u20131330. https:\/\/doi.org\/10.1016\/j.biopsych.2006.03.051","journal-title":"Biol Psychiatry"},{"issue":"2","key":"2091_CR138","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrn2762","volume":"11","author":"S Diekelmann","year":"2010","unstructured":"Diekelmann S, Born J (2010) The memory function of sleep. Nat Rev Neurosci 11(2):114\u2013126. https:\/\/doi.org\/10.1038\/nrn2762","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"2091_CR139","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/1073858406292647","volume":"12","author":"J Born","year":"2006","unstructured":"Born J, Rasch B, Gais S (2006) Sleep to remember. Neuroscientist 12(5):410\u2013424. https:\/\/doi.org\/10.1177\/1073858406292647","journal-title":"Neuroscientist"},{"issue":"6","key":"2091_CR140","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1101\/lm.77104","volume":"11","author":"JD Payne","year":"2004","unstructured":"Payne JD, Nadel L (2004) Sleep, dreams, and memory consolidation: the role of the stress hormone cortisol. Learn Mem 11(6):671\u2013678. https:\/\/doi.org\/10.1101\/lm.77104","journal-title":"Learn Mem"},{"issue":"3","key":"2091_CR141","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/cercor\/bht255","volume":"25","author":"KA Bennion","year":"2015","unstructured":"Bennion KA, Mickley Steinmetz KR, Kensinger EA, Payne JD (2015) Sleep and cortisol interact to support memory consolidation. Cereb Cortex 25(3):646\u2013657. https:\/\/doi.org\/10.1093\/cercor\/bht255","journal-title":"Cereb Cortex"},{"issue":"2","key":"2091_CR142","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1053\/smrv.2001.0159","volume":"6","author":"A Steiger","year":"2002","unstructured":"Steiger A (2002) Sleep and the hypothalamo-pituitary-adrenocortical system. Sleep Med Rev 6(2):125\u2013138. https:\/\/doi.org\/10.1053\/smrv.2001.0159","journal-title":"Sleep Med Rev"},{"issue":"12","key":"2091_CR143","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1016\/j.psyneuen.2013.08.006","volume":"38","author":"S Groch","year":"2013","unstructured":"Groch S, Wilhelm I, Lange T, Born J (2013) Differential contribution of mineralocorticoid and glucocorticoid receptors to memory formation during sleep. Psychoneuroendocrinology 38(12):2962\u20132972. https:\/\/doi.org\/10.1016\/j.psyneuen.2013.08.006","journal-title":"Psychoneuroendocrinology"},{"key":"2091_CR144","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.physbeh.2015.08.011","volume":"151","author":"M Henry","year":"2015","unstructured":"Henry M, Wolf PS, Ross IL, Thomas KG (2015) Poor quality of life, depressed mood, and memory impairment may be mediated by sleep disruption in patients with Addison\u2019s disease. Physiol Behav 151:379\u2013385. https:\/\/doi.org\/10.1016\/j.physbeh.2015.08.011","journal-title":"Physiol Behav"},{"issue":"10","key":"2091_CR145","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1210\/jc.2007-0685","volume":"92","author":"S Hahner","year":"2007","unstructured":"Hahner S, Loeffler M, Fassnacht M, Weismann D, Koschker AC, Quinkler M et al (2007) Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 92(10):3912\u20133922. https:\/\/doi.org\/10.1210\/jc.2007-0685","journal-title":"J Clin Endocrinol Metab"},{"key":"2091_CR146","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000439329","volume":"30","author":"A Mallappa","year":"2016","unstructured":"Mallappa A, Debono M (2016) Recent advances in hydrocortisone replacement treatment. Endocr Dev 30:42\u201353. https:\/\/doi.org\/10.1159\/000439329","journal-title":"Endocr Dev"},{"issue":"11","key":"2091_CR147","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1210\/jcem.85.11.6965","volume":"85","author":"D Garcia-Borreguero","year":"2000","unstructured":"Garcia-Borreguero D, Wehr TA, Larrosa O, Granizo JJ, Hardwick D, Chrousos GP et al (2000) Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency. J Clin Endocrinol Metab 85(11):4201\u20134206. https:\/\/doi.org\/10.1210\/jcem.85.11.6965","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2091_CR148","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1210\/jc.2014-4328","volume":"100","author":"SM Staufenbiel","year":"2015","unstructured":"Staufenbiel SM, Andela CD, Manenschijn L, Pereira AM, van Rossum EF, Biermasz NR (2015) Increased hair cortisol concentrations and BMI in patients with pituitary-adrenal disease on hydrocortisone replacement. J Clin Endocrinol Metab 100(6):2456\u20132462. https:\/\/doi.org\/10.1210\/jc.2014-4328","journal-title":"J Clin Endocrinol Metab"},{"key":"2091_CR149","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.psyneuen.2017.02.004","volume":"78","author":"M Henry","year":"2017","unstructured":"Henry M, Ross IL, Wolf PSA, Thomas KGF (2017) Impaired quality and efficiency of sleep impairs cognitive functioning in Addison\u2019s disease. Psychoneuroendocrinology 78:237\u2013245. https:\/\/doi.org\/10.1016\/j.psyneuen.2017.02.004","journal-title":"Psychoneuroendocrinology"},{"issue":"10108","key":"2091_CR150","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","volume":"390","author":"D El-Maouche","year":"2017","unstructured":"El-Maouche D, Arlt W, Merke DP (2017) Congenital adrenal hyperplasia. Lancet 390(10108):2194\u20132210. https:\/\/doi.org\/10.1016\/S0140-6736(17)31431-9","journal-title":"Lancet"},{"issue":"3","key":"2091_CR151","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/EJE-18-0279","volume":"179","author":"WL Miller","year":"2018","unstructured":"Miller WL (2018) Mechanisms in endocrinology: rare defects in adrenal steroidogenesis. Eur J Endocrinol 179(3):R125\u2013R141. https:\/\/doi.org\/10.1530\/EJE-18-0279","journal-title":"Eur J Endocrinol"},{"issue":"4 Pt 1","key":"2091_CR152","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.lpm.2013.10.006","volume":"43","author":"A Bachelot","year":"2014","unstructured":"Bachelot A, Touraine P (2014) Health status of adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Presse Med 43(4 Pt 1):428\u2013437. https:\/\/doi.org\/10.1016\/j.lpm.2013.10.006","journal-title":"Presse Med"},{"issue":"1","key":"2091_CR153","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","volume":"43","author":"HL Claahsen-van der Grinten","year":"2022","unstructured":"Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H et al (2022) Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management. Endocr Rev 43(1):91\u2013159. https:\/\/doi.org\/10.1210\/endrev\/bnab016","journal-title":"Endocr Rev"},{"issue":"2","key":"2091_CR154","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/1872214809666151005123928","volume":"9","author":"E Przybylik-Mazurek","year":"2015","unstructured":"Przybylik-Mazurek E, Kurzynska A, Skalniak A, Hubalewska-Dydejczyk A (2015) Current approaches to the diagnosis of classical form of congenital adrenal hyperplasia. Recent Pat Endocr Metab Immune Drug Discov 9(2):103\u2013110. https:\/\/doi.org\/10.2174\/1872214809666151005123928","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"issue":"11","key":"2091_CR155","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP et al (2018) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103(11):4043\u20134088. https:\/\/doi.org\/10.1210\/jc.2018-01865","journal-title":"J Clin Endocrinol Metab"},{"key":"2091_CR156","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.yhbeh.2014.11.014","volume":"67","author":"WV Browne","year":"2015","unstructured":"Browne WV, Hindmarsh PC, Pasterski V, Hughes IA, Acerini CL, Spencer D et al (2015) Working memory performance is reduced in children with congenital adrenal hyperplasia. Horm Behav 67:83\u201388. https:\/\/doi.org\/10.1016\/j.yhbeh.2014.11.014","journal-title":"Horm Behav"},{"issue":"4","key":"2091_CR157","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0306-4530(94)90015-9","volume":"19","author":"J Helleday","year":"1994","unstructured":"Helleday J, Bartfai A, Ritzen EM, Forsman M (1994) General intelligence and cognitive profile in women with congenital adrenal hyperplasia (CAH). Psychoneuroendocrinology 19(4):343\u2013356. https:\/\/doi.org\/10.1016\/0306-4530(94)90015-9","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"2091_CR158","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/cen.13441","volume":"87","author":"L Karlsson","year":"2017","unstructured":"Karlsson L, Gezelius A, Nordenstrom A, Hirvikoski T, Lajic S (2017) Cognitive impairment in adolescents and adults with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 87(6):651\u2013659. https:\/\/doi.org\/10.1111\/cen.13441","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2091_CR159","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.psyneuen.2007.11.006","volume":"33","author":"FS Maheu","year":"2008","unstructured":"Maheu FS, Merke DP, Schroth EA, Keil MF, Hardin J, Poeth K et al (2008) Steroid abnormalities and the developing brain: declarative memory for emotionally arousing and neutral material in children with congenital adrenal hyperplasia. Psychoneuroendocrinology 33(2):238\u2013245. https:\/\/doi.org\/10.1016\/j.psyneuen.2007.11.006","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"2091_CR160","first-page":"1","volume":"63","author":"F Somajni","year":"2011","unstructured":"Somajni F, Sovera V, Albizzati A, Russo G, Peroni P, Seragni G et al (2011) Neuropsychological assessment in prepubertal patients with congenital adrenal hyperplasia: preliminary study. Minerva Pediatr 63(1):1\u20139","journal-title":"Minerva Pediatr"},{"issue":"2","key":"2091_CR161","doi-asserted-by":"publisher","first-page":"113","DOI":"10.20945\/2359-3997000000125","volume":"63","author":"NH Amr","year":"2019","unstructured":"Amr NH, Baioumi AY, Serour MN, Khalifa A, Shaker NM (2019) Cognitive functions in children with congenital adrenal hyperplasia. Arch Endocrinol Metab 63(2):113\u2013120. https:\/\/doi.org\/10.20945\/2359-3997000000125","journal-title":"Arch Endocrinol Metab"},{"issue":"4","key":"2091_CR162","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1210\/jc.2013-3326","volume":"99","author":"A Strandqvist","year":"2014","unstructured":"Strandqvist A, Falhammar H, Lichtenstein P, Hirschberg AL, Wedell A, Norrby C et al (2014) Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden. J Clin Endocrinol Metab 99(4):1425\u20131432. https:\/\/doi.org\/10.1210\/jc.2013-3326","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2091_CR163","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00431-018-3226-7","volume":"177","author":"SA Hamed","year":"2018","unstructured":"Hamed SA, Metwalley KA, Farghaly HS (2018) Cognitive function in children with classic congenital adrenal hyperplasia. Eur J Pediatr 177(11):1633\u20131640. https:\/\/doi.org\/10.1007\/s00431-018-3226-7","journal-title":"Eur J Pediatr"},{"issue":"4","key":"2091_CR164","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1210\/jc.2005-1959","volume":"91","author":"TH Johannsen","year":"2006","unstructured":"Johannsen TH, Ripa CP, Reinisch JM, Schwartz M, Mortensen EL, Main KM (2006) Impaired cognitive function in women with congenital adrenal hyperplasia. J Clin Endocrinol Metab 91(4):1376\u20131381. https:\/\/doi.org\/10.1210\/jc.2005-1959","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2091_CR165","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/088307389100600404","volume":"6","author":"R Nass","year":"1991","unstructured":"Nass R, Baker S (1991) Learning disabilities in children with congenital adrenal hyperplasia. J Child Neurol 6(4):306\u2013312. https:\/\/doi.org\/10.1177\/088307389100600404","journal-title":"J Child Neurol"},{"issue":"3","key":"2091_CR166","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/jcem-50-3-586","volume":"50","author":"S Pang","year":"1980","unstructured":"Pang S, Levine LS, Lorenzen F, Chow D, Pollack M, Dupont B et al (1980) Hormonal studies in obligate heterozygotes and siblings of patients with 11 beta-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 50(3):586\u2013589. https:\/\/doi.org\/10.1210\/jcem-50-3-586","journal-title":"J Clin Endocrinol Metab"},{"key":"2091_CR167","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-neuro-061010-113654","volume":"34","author":"M Hines","year":"2011","unstructured":"Hines M (2011) Gender development and the human brain. Annu Rev Neurosci 34:69\u201388. https:\/\/doi.org\/10.1146\/annurev-neuro-061010-113654","journal-title":"Annu Rev Neurosci"},{"key":"2091_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0198-y","author":"MV Lombardo","year":"2018","unstructured":"Lombardo MV, Auyeung B, Pramparo T, Quartier A, Courraud J, Holt RJ et al (2018) Sex-specific impact of prenatal androgens on social brain default mode subsystems. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-018-0198-y","journal-title":"Mol Psychiatry"},{"issue":"4","key":"2091_CR169","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.biopsych.2018.01.002","volume":"84","author":"A Quartier","year":"2018","unstructured":"Quartier A, Chatrousse L, Redin C, Keime C, Haumesser N, Maglott-Roth A et al (2018) Genes and pathways regulated by androgens in human neural cells, potential candidates for the male excess in autism spectrum disorder. Biol Psychiatry 84(4):239\u2013252. https:\/\/doi.org\/10.1016\/j.biopsych.2018.01.002","journal-title":"Biol Psychiatry"},{"issue":"5","key":"2091_CR170","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/hipo.10207","volume":"14","author":"C Isgor","year":"2004","unstructured":"Isgor C, Kabbaj M, Akil H, Watson SJ (2004) Delayed effects of chronic variable stress during peripubertal-juvenile period on hippocampal morphology and on cognitive and stress axis functions in rats. Hippocampus 14(5):636\u2013648. https:\/\/doi.org\/10.1002\/hipo.10207","journal-title":"Hippocampus"},{"key":"2091_CR171","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuroscience.2016.05.046","volume":"330","author":"JK McCreary","year":"2016","unstructured":"McCreary JK, Truica LS, Friesen B, Yao Y, Olson DM, Kovalchuk I et al (2016) Altered brain morphology and functional connectivity reflect a vulnerable affective state after cumulative multigenerational stress in rats. Neuroscience 330:79\u201389. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.05.046","journal-title":"Neuroscience"},{"issue":"2","key":"2091_CR172","doi-asserted-by":"publisher","first-page":"E102","DOI":"10.1152\/ajpendo.00368.2019","volume":"318","author":"S Travers","year":"2020","unstructured":"Travers S, Bouvattier C, Fagart J, Martinerie L, Viengchareun S, Pussard E et al (2020) Interaction between accumulated 21-deoxysteroids and mineralocorticoid signaling in 21-hydroxylase deficiency. Am J Physiol Endocrinol Metab 318(2):E102\u2013E110. https:\/\/doi.org\/10.1152\/ajpendo.00368.2019","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"2091_CR173","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1037\/0033-2909.117.2.250","volume":"117","author":"D Voyer","year":"1995","unstructured":"Voyer D, Voyer S, Bryden MP (1995) Magnitude of sex differences in spatial abilities: a meta-analysis and consideration of critical variables. Psychol Bull 117(2):250\u2013270. https:\/\/doi.org\/10.1037\/0033-2909.117.2.250","journal-title":"Psychol Bull"},{"issue":"1","key":"2091_CR174","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1037\/a0026652","volume":"126","author":"SA Berenbaum","year":"2012","unstructured":"Berenbaum SA, Bryk KL, Beltz AM (2012) Early androgen effects on spatial and mechanical abilities: evidence from congenital adrenal hyperplasia. Behav Neurosci 126(1):86\u201396. https:\/\/doi.org\/10.1037\/a0026652","journal-title":"Behav Neurosci"},{"issue":"2","key":"2091_CR175","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.psyneuen.2008.09.007","volume":"34","author":"ML Collaer","year":"2009","unstructured":"Collaer ML, Brook CG, Conway GS, Hindmarsh PC, Hines M (2009) Motor development in individuals with congenital adrenal hyperplasia: strength, targeting, and fine motor skill. Psychoneuroendocrinology 34(2):249\u2013258. https:\/\/doi.org\/10.1016\/j.psyneuen.2008.09.007","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"2091_CR176","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.psyneuen.2008.04.005","volume":"33","author":"SC Mueller","year":"2008","unstructured":"Mueller SC, Temple V, Oh E, VanRyzin C, Williams A, Cornwell B et al (2008) Early androgen exposure modulates spatial cognition in congenital adrenal hyperplasia (CAH). Psychoneuroendocrinology 33(7):973\u2013980. https:\/\/doi.org\/10.1016\/j.psyneuen.2008.04.005","journal-title":"Psychoneuroendocrinology"},{"key":"2091_CR177","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.psyneuen.2015.11.010","volume":"64","author":"ML Collaer","year":"2016","unstructured":"Collaer ML, Hindmarsh PC, Pasterski V, Fane BA, Hines M (2016) Reduced short term memory in congenital adrenal hyperplasia (CAH) and its relationship to spatial and quantitative performance. Psychoneuroendocrinology 64:164\u2013173. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.11.010","journal-title":"Psychoneuroendocrinology"},{"key":"2091_CR178","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa016","author":"V Messina","year":"2020","unstructured":"Messina V, Karlsson L, Hirvikoski T, Nordenstrom A, Lajic S (2020) Cognitive function of children and adolescents with congenital adrenal hyperplasia: importance of early diagnosis. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2091_CR179","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1530\/EJE-08-0874","volume":"160","author":"M Debono","year":"2009","unstructured":"Debono M, Ross RJ, Newell-Price J (2009) Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol 160(5):719\u2013729. https:\/\/doi.org\/10.1530\/EJE-08-0874","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2091_CR180","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000327794","volume":"76","author":"N Reisch","year":"2011","unstructured":"Reisch N, Arlt W, Krone N (2011) Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res Paediatr 76(2):73\u201385. https:\/\/doi.org\/10.1159\/000327794","journal-title":"Horm Res Paediatr"},{"issue":"13","key":"2091_CR181","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1523\/JNEUROSCI.3420-04.2005","volume":"25","author":"LL Eldridge","year":"2005","unstructured":"Eldridge LL, Engel SA, Zeineh MM, Bookheimer SY, Knowlton BJ (2005) A dissociation of encoding and retrieval processes in the human hippocampus. J Neurosci 25(13):3280\u20133286. https:\/\/doi.org\/10.1523\/JNEUROSCI.3420-04.2005","journal-title":"J Neurosci"},{"issue":"1","key":"2091_CR182","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1101\/lm.1971111","volume":"18","author":"JW Lacy","year":"2011","unstructured":"Lacy JW, Yassa MA, Stark SM, Muftuler LT, Stark CE (2011) Distinct pattern separation related transfer functions in human CA3\/dentate and CA1 revealed using high-resolution fMRI and variable mnemonic similarity. Learn Mem 18(1):15\u201318. https:\/\/doi.org\/10.1101\/lm.1971111","journal-title":"Learn Mem"},{"issue":"3","key":"2091_CR183","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1469-7580.2005.00446.x","volume":"207","author":"S O'Mara","year":"2005","unstructured":"O\u2019Mara S (2005) The subiculum: what it does, what it might do, and what neuroanatomy has yet to tell us. J Anat 207(3):271\u2013282. https:\/\/doi.org\/10.1111\/j.1469-7580.2005.00446.x","journal-title":"J Anat"},{"issue":"4","key":"2091_CR184","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3109\/10253890.2011.586446","volume":"14","author":"JG Tasker","year":"2011","unstructured":"Tasker JG, Herman JP (2011) Mechanisms of rapid glucocorticoid feedback inhibition of the hypothalamic-pituitary-adrenal axis. Stress 14(4):398\u2013406. https:\/\/doi.org\/10.3109\/10253890.2011.586446","journal-title":"Stress"},{"issue":"4","key":"2091_CR185","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1210\/jc.2002-021730","volume":"88","author":"DP Merke","year":"2003","unstructured":"Merke DP, Fields JD, Keil MF, Vaituzis AC, Chrousos GP, Giedd JN (2003) Children with classic congenital adrenal hyperplasia have decreased amygdala volume: potential prenatal and postnatal hormonal effects. J Clin Endocrinol Metab 88(4):1760\u20131765. https:\/\/doi.org\/10.1210\/jc.2002-021730","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2091_CR186","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ando.2018.03.007","volume":"79","author":"SM Webb","year":"2018","unstructured":"Webb SM, Santos A, Resmini E, Martinez-Momblan MA, Martel L, Valassi E (2018) Quality of life in Cushing\u2019s disease: a long term issue? Ann Endocrinol (Paris) 79(3):132\u2013137. https:\/\/doi.org\/10.1016\/j.ando.2018.03.007","journal-title":"Ann Endocrinol (Paris)"},{"issue":"5","key":"2091_CR187","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1093\/cercor\/bhz274","volume":"30","author":"A Van't Westeinde","year":"2020","unstructured":"Van\u2019t Westeinde A, Karlsson L, Thomsen Sandberg M, Nordenstrom A, Padilla N, Lajic S (2020) Altered Gray matter structure and white matter microstructure in patients with congenital adrenal hyperplasia: relevance for working memory performance. Cereb Cortex 30(5):2777\u20132788. https:\/\/doi.org\/10.1093\/cercor\/bhz274","journal-title":"Cereb Cortex"},{"issue":"3","key":"2091_CR188","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/archneur.63.3.413","volume":"63","author":"R Bergamaschi","year":"2006","unstructured":"Bergamaschi R, Livieri C, Uggetti C, Candeloro E, Egitto MG, Pichiecchio A et al (2006) Brain white matter impairment in congenital adrenal hyperplasia. Arch Neurol 63(3):413\u2013416. https:\/\/doi.org\/10.1001\/archneur.63.3.413","journal-title":"Arch Neurol"},{"issue":"5","key":"2091_CR189","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.braindev.2009.04.004","volume":"32","author":"C Gaudiano","year":"2010","unstructured":"Gaudiano C, Malandrini A, Pollazzon M, Murru S, Mari F, Renieri A et al (2010) Leukoencephalopathy in 21-beta hydroxylase deficiency: report of a family. Brain Dev 32(5):421\u2013424. https:\/\/doi.org\/10.1016\/j.braindev.2009.04.004","journal-title":"Brain Dev"},{"issue":"3","key":"2091_CR190","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/088307389701200306","volume":"12","author":"R Nass","year":"1997","unstructured":"Nass R, Heier L, Moshang T, Oberfield S, George A, New MI et al (1997) Magnetic resonance imaging in the congenital adrenal hyperplasia population: increased frequency of white-matter abnormalities and temporal lobe atrophy. J Child Neurol 12(3):181\u2013186. https:\/\/doi.org\/10.1177\/088307389701200306","journal-title":"J Child Neurol"},{"issue":"1","key":"2091_CR191","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuron.2015.09.020","volume":"88","author":"J Eriksson","year":"2015","unstructured":"Eriksson J, Vogel EK, Lansner A, Bergstrom F, Nyberg L (2015) Neurocognitive architecture of working memory. Neuron 88(1):33\u201346. https:\/\/doi.org\/10.1016\/j.neuron.2015.09.020","journal-title":"Neuron"},{"issue":"2","key":"2091_CR192","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12640-016-9630-8","volume":"30","author":"A Kurek","year":"2016","unstructured":"Kurek A, Kucharczyk M, Detka J, Slusarczyk J, Trojan E, Glombik K et al (2016) Pro-apoptotic action of corticosterone in hippocampal organotypic cultures. Neurotox Res 30(2):225\u2013238. https:\/\/doi.org\/10.1007\/s12640-016-9630-8","journal-title":"Neurotox Res"},{"issue":"1","key":"2091_CR193","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/2230-8210.107833","volume":"17","author":"MF Mnif","year":"2013","unstructured":"Mnif MF, Kamoun M, Mnif F, Charfi N, Kallel N, Rekik N et al (2013) Brain magnetic resonance imaging findings in adult patients with congenital adrenal hyperplasia: Increased frequency of white matter impairment and temporal lobe structures dysgenesis. Indian J Endocrinol Metab 17(1):121\u2013127. https:\/\/doi.org\/10.4103\/2230-8210.107833","journal-title":"Indian J Endocrinol Metab"},{"key":"2091_CR194","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa023","author":"MM Herting","year":"2020","unstructured":"Herting MM, Azad A, Kim R, Tyszka JM, Geffner ME, Kim MS (2020) Brain differences in the prefrontal cortex, amygdala, and hippocampus in youth with congenital adrenal hyperplasia. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2091_CR195","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/cphy.c130035","volume":"4","author":"H Raff","year":"2014","unstructured":"Raff H, Sharma ST, Nieman LK (2014) Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing\u2019s syndrome, adrenal insufficiency, and congenital adrenal hyperplasia. Compr Physiol 4(2):739\u2013769. https:\/\/doi.org\/10.1002\/cphy.c130035","journal-title":"Compr Physiol"},{"key":"2091_CR196","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.yfrne.2018.02.003","volume":"49","author":"ER de Kloet","year":"2018","unstructured":"de Kloet ER, Meijer OC, de Nicola AF, de Rijk RH, Joels M (2018) Importance of the brain corticosteroid receptor balance in metaplasticity, cognitive performance and neuro-inflammation. Front Neuroendocrinol 49:124\u2013145. https:\/\/doi.org\/10.1016\/j.yfrne.2018.02.003","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"2091_CR197","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/cphy.c150015","volume":"6","author":"JP Herman","year":"2016","unstructured":"Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R et al (2016) Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol 6(2):603\u2013621. https:\/\/doi.org\/10.1002\/cphy.c150015","journal-title":"Compr Physiol"},{"issue":"3","key":"2091_CR198","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/s0149-7634(03)00033-2","volume":"27","author":"K Erickson","year":"2003","unstructured":"Erickson K, Drevets W, Schulkin J (2003) Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states. Neurosci Biobehav Rev 27(3):233\u2013246. https:\/\/doi.org\/10.1016\/s0149-7634(03)00033-2","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"2091_CR199","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0959-4388(02)00301-x","volume":"12","author":"R Adolphs","year":"2002","unstructured":"Adolphs R (2002) Neural systems for recognizing emotion. Curr Opin Neurobiol 12(2):169\u2013177. https:\/\/doi.org\/10.1016\/s0959-4388(02)00301-x","journal-title":"Curr Opin Neurobiol"},{"issue":"17","key":"2091_CR200","doi-asserted-by":"publisher","first-page":"R764","DOI":"10.1016\/j.cub.2013.05.041","volume":"23","author":"AR Preston","year":"2013","unstructured":"Preston AR, Eichenbaum H (2013) Interplay of hippocampus and prefrontal cortex in memory. Curr Biol 23(17):R764\u2013R773. https:\/\/doi.org\/10.1016\/j.cub.2013.05.041","journal-title":"Curr Biol"},{"issue":"5","key":"2091_CR201","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ajog.2012.10.885","volume":"208","author":"WL Miller","year":"2013","unstructured":"Miller WL, Witchel SF (2013) Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits. Am J Obstet Gynecol 208(5):354\u2013359. https:\/\/doi.org\/10.1016\/j.ajog.2012.10.885","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"2091_CR202","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1210\/jc.2012-1970","volume":"97","author":"N Alexander","year":"2012","unstructured":"Alexander N, Rosenlocher F, Stalder T, Linke J, Distler W, Morgner J et al (2012) Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children. J Clin Endocrinol Metab 97(10):3538\u20133544. https:\/\/doi.org\/10.1210\/jc.2012-1970","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2091_CR203","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081394","volume":"8","author":"N Khalife","year":"2013","unstructured":"Khalife N, Glover V, Taanila A, Ebeling H, Jarvelin MR, Rodriguez A (2013) Prenatal glucocorticoid treatment and later mental health in children and adolescents. PLoS ONE 8(11):e81394. https:\/\/doi.org\/10.1371\/journal.pone.0081394","journal-title":"PLoS ONE"},{"issue":"1","key":"2091_CR204","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1710-1492-9-30","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R et al (2013) A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 9(1):30. https:\/\/doi.org\/10.1186\/1710-1492-9-30","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"12","key":"2091_CR205","doi-asserted-by":"publisher","first-page":"6343","DOI":"10.1210\/en.2008-0615","volume":"149","author":"J Hauser","year":"2008","unstructured":"Hauser J, Knapman A, Zurcher NR, Pilloud S, Maier C, Diaz-Heijtz R et al (2008) Effects of prenatal dexamethasone treatment on physical growth, pituitary-adrenal hormones, and performance of motor, motivational, and cognitive tasks in juvenile and adolescent common marmoset monkeys. Endocrinology 149(12):6343\u20136355. https:\/\/doi.org\/10.1210\/en.2008-0615","journal-title":"Endocrinology"},{"issue":"4","key":"2091_CR206","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0306-4530(94)00070-0","volume":"20","author":"PD Trautman","year":"1995","unstructured":"Trautman PD, Meyer-Bahlburg HF, Postelnek J, New MI (1995) Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology 20(4):439\u2013449. https:\/\/doi.org\/10.1016\/0306-4530(94)00070-0","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"2091_CR207","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1210\/jc.2006-1340","volume":"92","author":"T Hirvikoski","year":"2007","unstructured":"Hirvikoski T, Nordenstrom A, Lindholm T, Lindblad F, Ritzen EM, Wedell A et al (2007) Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab 92(2):542\u2013548. https:\/\/doi.org\/10.1210\/jc.2006-1340","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2091_CR208","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-2265.2010.03826.x","volume":"73","author":"M Merce Fernandez-Balsells","year":"2010","unstructured":"Merce Fernandez-Balsells M, Muthusamy K, Smushkin G, Lampropulos JF, Elamin MB, Abu Elnour NO et al (2010) Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses. Clin Endocrinol (Oxf) 73(4):436\u2013444. https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03826.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2091_CR209","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1530\/EJE-11-0789","volume":"167","author":"HF Meyer-Bahlburg","year":"2012","unstructured":"Meyer-Bahlburg HF, Dolezal C, Haggerty R, Silverman M, New MI (2012) Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol 167(1):103\u2013110. https:\/\/doi.org\/10.1530\/EJE-11-0789","journal-title":"Eur J Endocrinol"},{"key":"2091_CR210","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/164_2016_98","volume":"237","author":"IM Adcock","year":"2017","unstructured":"Adcock IM, Mumby S (2017) Glucocorticoids. Handb Exp Pharmacol 237:171\u2013196. https:\/\/doi.org\/10.1007\/164_2016_98","journal-title":"Handb Exp Pharmacol"},{"issue":"11","key":"2091_CR211","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","volume":"50","author":"L Fardet","year":"2011","unstructured":"Fardet L, Petersen I, Nazareth I (2011) Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years. Rheumatology (Oxford) 50(11):1982\u20131990. https:\/\/doi.org\/10.1093\/rheumatology\/ker017","journal-title":"Rheumatology (Oxford)"},{"key":"2091_CR212","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1415","volume":"357","author":"AK Waljee","year":"2017","unstructured":"Waljee AK, Rogers MA, Lin P, Singal AG, Stein JD, Marks RM et al (2017) Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ 357:j1415. https:\/\/doi.org\/10.1136\/bmj.j1415","journal-title":"BMJ"},{"issue":"5","key":"2091_CR213","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1530\/EJE-22-0454","volume":"187","author":"M Minnetti","year":"2022","unstructured":"Minnetti M, Hasenmajer V, Sbardella E, Angelini F, Simeoli C, Di Paola N et al (2022) Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool. Eur J Endocrinol 187(5):719\u2013731. https:\/\/doi.org\/10.1530\/EJE-22-0454","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2091_CR214","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s40618-019-01146-y","volume":"43","author":"AM Isidori","year":"2020","unstructured":"Isidori AM, Arnaldi G, Boscaro M, Falorni A, Giordano C, Giordano R et al (2020) Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion. J Endocrinol Invest 43(5):683\u2013696. https:\/\/doi.org\/10.1007\/s40618-019-01146-y","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2091_CR215","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41467-023-36541-w","volume":"14","author":"N Othonos","year":"2023","unstructured":"Othonos N, Pofi R, Arvaniti A, White S, Bonaventura I, Nikolaou N et al (2023) 11beta-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial. Nat Commun 14(1):1025. https:\/\/doi.org\/10.1038\/s41467-023-36541-w","journal-title":"Nat Commun"},{"issue":"2","key":"2091_CR216","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.psym.2011.12.007","volume":"53","author":"AN Dubovsky","year":"2012","unstructured":"Dubovsky AN, Arvikar S, Stern TA, Axelrod L (2012) The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Psychosomatics 53(2):103\u2013115. https:\/\/doi.org\/10.1016\/j.psym.2011.12.007","journal-title":"Psychosomatics"},{"key":"2091_CR217","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1176\/ajp.141.3.369","volume":"141","author":"NR Varney","year":"1984","unstructured":"Varney NR, Alexander B, MacIndoe JH (1984) Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 141:369\u2013372","journal-title":"Am J Psychiatry"},{"issue":"4","key":"2091_CR218","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00005053-197904000-00006","volume":"167","author":"RC Hall","year":"1979","unstructured":"Hall RC, Popkin MK, Stickney SK, Gardner ER (1979) Presentation of the steroid psychoses. J Nerv Ment Dis 167(4):229\u2013236. https:\/\/doi.org\/10.1097\/00005053-197904000-00006","journal-title":"J Nerv Ment Dis"},{"issue":"5","key":"2091_CR219","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.biopsych.2003.09.010","volume":"55","author":"ES Brown","year":"2004","unstructured":"Brown ES, D JW, Frol A, Bobadilla L, Khan DA, Hanczyc M et al (2004) Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 55(5):538\u2013545. https:\/\/doi.org\/10.1016\/j.biopsych.2003.09.010","journal-title":"Biol Psychiatry"},{"issue":"6","key":"2091_CR220","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1212\/wnl.47.6.1396","volume":"47","author":"PA Keenan","year":"1996","unstructured":"Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT (1996) The effect on memory of chronic prednisone treatment in patients with systemic disease. Am Acad Neurol 47(6):1396\u20131402. https:\/\/doi.org\/10.1212\/wnl.47.6.1396","journal-title":"Am Acad Neurol"},{"issue":"2","key":"2091_CR221","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1212\/01.WNL.0000149523.35039.4C","volume":"64","author":"R Brunner","year":"2005","unstructured":"Brunner R, Schaefer D, Hess K, Parzer P, Resch F, Schwab S (2005) Effect of corticosteroids on short-term and long-term memory. Neurology 64(2):335\u2013337. https:\/\/doi.org\/10.1212\/01.WNL.0000149523.35039.4C","journal-title":"Neurology"},{"issue":"3","key":"2091_CR222","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/13554790701475468","volume":"13","author":"OM Wolkowitz","year":"2007","unstructured":"Wolkowitz OM, Lupien SJ, Bigler ED (2007) The \u201csteroid dementia syndrome\u201d: a possible model of human glucocorticoid neurotoxicity. Neurocase 13(3):189\u2013200. https:\/\/doi.org\/10.1080\/13554790701475468","journal-title":"Neurocase"},{"issue":"3","key":"2091_CR223","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1210\/en.2016-1495","volume":"158","author":"OC Meijer","year":"2017","unstructured":"Meijer OC, de Kloet ER (2017) A refill for the brain mineralocorticoid receptor: the benefit of cortisol add-on to dexamethasone therapy. Endocrinology 158(3):448\u2013454. https:\/\/doi.org\/10.1210\/en.2016-1495","journal-title":"Endocrinology"},{"issue":"19","key":"2091_CR224","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1200\/JCO.2015.66.0761","volume":"34","author":"LT Warris","year":"2016","unstructured":"Warris LT, van den Heuvel-Eibrink MM, Aarsen FK, Pluijm SM, Bierings MB, van den Bos C et al (2016) Hydrocortisone as an intervention for dexamethasone-induced adverse effects in Pediatric patients with acute lymphoblastic Leukemia: results of a double-blind, randomized controlled trial. J Clin Oncol 34(19):2287\u20132293. https:\/\/doi.org\/10.1200\/JCO.2015.66.0761","journal-title":"J Clin Oncol"},{"issue":"7","key":"2091_CR225","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/pbc.24988","volume":"61","author":"LT Warris","year":"2014","unstructured":"Warris LT, van den Heuvel-Eibrink MM, den Hoed MA, Aarsen FK, Pieters R, van den Akker EL (2014) Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review. Pediatr Blood Cancer 61(7):1313\u20131318. https:\/\/doi.org\/10.1002\/pbc.24988","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"2091_CR226","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/pbc.24666","volume":"60","author":"DP Waber","year":"2013","unstructured":"Waber DP, McCabe M, Sebree M, Forbes PW, Adams H, Alyman C et al (2013) Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00\u201301. Pediatr Blood Cancer 60(11):1785\u20131791. https:\/\/doi.org\/10.1002\/pbc.24666","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"2091_CR227","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1182\/blood-2008-12-186502","volume":"114","author":"NS Kadan-Lottick","year":"2009","unstructured":"Kadan-Lottick NS, Brouwers P, Breiger D, Kaleita T, Dziura J, Liu H et al (2009) A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia. Blood 114(9):1746\u20131752. https:\/\/doi.org\/10.1182\/blood-2008-12-186502","journal-title":"Blood"},{"issue":"3","key":"2091_CR228","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1006\/nlme.2002.4080","volume":"78","author":"B Roozendaal","year":"2002","unstructured":"Roozendaal B (2002) Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol Learn Mem 78(3):578\u2013595. https:\/\/doi.org\/10.1006\/nlme.2002.4080","journal-title":"Neurobiol Learn Mem"},{"issue":"4","key":"2091_CR229","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.neubiorev.2009.11.015","volume":"34","author":"L Schwabe","year":"2010","unstructured":"Schwabe L, Wolf OT, Oitzl MS (2010) Memory formation under stress: quantity and quality. Neurosci Biobehav Rev 34(4):584\u2013591. https:\/\/doi.org\/10.1016\/j.neubiorev.2009.11.015","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"2091_CR230","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.actpsy.2007.08.002","volume":"127","author":"OT Wolf","year":"2008","unstructured":"Wolf OT (2008) The influence of stress hormones on emotional memory: relevance for psychopathology. Acta Psychol (Amst) 127(3):513\u2013531. https:\/\/doi.org\/10.1016\/j.actpsy.2007.08.002","journal-title":"Acta Psychol (Amst)"},{"key":"2091_CR231","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1749-6632.1995.tb31402.x","volume":"761","author":"PA Keenan","year":"1995","unstructured":"Keenan PA, Jacobson MW, Soleymani RM, Newcomer AJW (1995) Commonly used therapeutic doses of glucocorticoids impair explicit memory. Ann NY Acad Sci 761:400\u2013402. https:\/\/doi.org\/10.1111\/j.1749-6632.1995.tb31402.x","journal-title":"Ann NY Acad Sci"},{"key":"2091_CR232","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1017\/S1355617712001014","volume":"19","author":"C Mrakotsky","year":"2012","unstructured":"Mrakotsky C, Forbes PW, Holmes Bernstein J, Grand RJ, Bousvaros A, Szigethy E et al (2012) Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease. J Int Neuropsychol Soc 19:96\u2013109","journal-title":"J Int Neuropsychol Soc"},{"issue":"4","key":"2091_CR233","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/73873","volume":"3","author":"DJ De Quervain","year":"2000","unstructured":"De Quervain DJ, Roozendaal B, Nitsch RM, McGaugh JL, Hock C (2000) Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nat Neurosci 3(4):313\u2013314. https:\/\/doi.org\/10.1038\/73873","journal-title":"Nat Neurosci"},{"issue":"17","key":"2091_CR234","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/0024-3205(96)00118-x","volume":"58","author":"C Kirschbaum","year":"1996","unstructured":"Kirschbaum C, Wolf OT, May M, Wippich W, Hellhammer DH (1996) Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci 58(17):1475\u20131483. https:\/\/doi.org\/10.1016\/0024-3205(96)00118-x","journal-title":"Life Sci"},{"issue":"8","key":"2091_CR235","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.psyneuen.2003.09.006","volume":"29","author":"C Buss","year":"2004","unstructured":"Buss C, Wolf OT, Witt J, Hellhammer DH (2004) Autobiographic memory impairment following acute cortisol administration. Psychoneuroendocrinology 29(8):1093\u20131096. https:\/\/doi.org\/10.1016\/j.psyneuen.2003.09.006","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"2091_CR236","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.psyneuen.2009.06.015","volume":"35","author":"N Schlosser","year":"2010","unstructured":"Schlosser N, Wolf OT, Fernando SC, Riedesel K, Otte C, Muhtz C et al (2010) Effects of acute cortisol administration on autobiographical memory in patients with major depression and healthy controls. Psychoneuroendocrinology 35(2):316\u2013320. https:\/\/doi.org\/10.1016\/j.psyneuen.2009.06.015","journal-title":"Psychoneuroendocrinology"},{"key":"2091_CR237","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/archpsyc.56.6.527","volume":"56","author":"AJW Newcomer","year":"1999","unstructured":"Newcomer AJW, Selke G, Melson AK, Hershey T, Craft S, Richards K et al (1999) Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 56:527\u2013533","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"2091_CR238","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00213-011-2286-4","volume":"217","author":"K Wingenfeld","year":"2011","unstructured":"Wingenfeld K, Wolf S, Krieg JC, Lautenbacher S (2011) Working memory performance and cognitive flexibility after dexamethasone or hydrocortisone administration in healthy volunteers. Psychopharmacology 217(3):323\u2013329. https:\/\/doi.org\/10.1007\/s00213-011-2286-4","journal-title":"Psychopharmacology"},{"issue":"13","key":"2091_CR239","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1523\/JNEUROSCI.4893-07.2008","volume":"28","author":"D Coluccia","year":"2008","unstructured":"Coluccia D, Wolf OT, Kollias S, Roozendaal B, Forster A, de Quervain DJ (2008) Glucocorticoid therapy-induced memory deficits: acute versus chronic effects. J Neurosci 28(13):3474\u20133478. https:\/\/doi.org\/10.1523\/JNEUROSCI.4893-07.2008","journal-title":"J Neurosci"},{"issue":"3","key":"2091_CR240","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/s0306-4530(01)00061-0","volume":"27","author":"SJ Lupien","year":"2002","unstructured":"Lupien SJ, Wilkinson CW, Briere S, Menard C, Ng Ying Kin NM, Nair NP (2002) The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology 27(3):401\u2013416. https:\/\/doi.org\/10.1016\/s0306-4530(01)00061-0","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"2091_CR241","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1037\/0735-7044.117.3.505","volume":"117","author":"HC Abercrombie","year":"2003","unstructured":"Abercrombie HC, Kalin NH, Thurow ME, Rosenkranz MA, Davidson RJ (2003) Cortisol variation in humans affects memory for emotionally laden and neutral information. Behav Neurosci 117(3):505\u2013516. https:\/\/doi.org\/10.1037\/0735-7044.117.3.505","journal-title":"Behav Neurosci"},{"key":"2091_CR242","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1749-6632.2009.04981.x","volume":"1179","author":"ES Brown","year":"2009","unstructured":"Brown ES (2009) Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci 1179:41\u201355. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04981.x","journal-title":"Ann N Y Acad Sci"},{"key":"2091_CR243","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1600-0404.1998.tb05967.x","volume":"97","author":"RL Oliveri","year":"1998","unstructured":"Oliveri RL, Sibilia G, Valentino P, Russo C, Romeo N, Quattrone A (1998) Pulsed methvltxednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis. Acta Neurol Scand 97:366\u2013369","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"2091_CR244","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/arclin\/12.2.167","volume":"12","author":"NR Varney","year":"1997","unstructured":"Varney NR (1997) A case of reversible steroid dementia. Arch Clin Neuropsychol 12(2):167\u2013171","journal-title":"Arch Clin Neuropsychol"},{"key":"2091_CR245","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-197801000-00003","author":"J Bentson","year":"1978","unstructured":"Bentson J, Reza M, Winter J, Wilson G (1978) Steroids and apparent cerebral atrophy on computed tomography scans. J Comput Assist Tomogr. https:\/\/doi.org\/10.1097\/00004728-197801000-00003","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"2091_CR246","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/00004728-198002000-00004","volume":"4","author":"T Okuno","year":"1980","unstructured":"Okuno T, Masatoshi I, Konishi K, Yoshioka M, Nakano Y (1980) Cerebral atrophy following ACTH therapy. J Comput Assist Tomogr 4(1):20\u201323","journal-title":"J Comput Assist Tomogr"},{"issue":"6","key":"2091_CR247","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jocn.2005.08.012","volume":"13","author":"C Chapman","year":"2006","unstructured":"Chapman C, Tubridy N, Cook MJ, Mitchell PJ, MacGregor LR, Lovelock C et al (2006) Short-term effects of methylprednisolone on cerebral volume in multiple sclerosis relapses. J Clin Neurosci 13(6):636\u2013638. https:\/\/doi.org\/10.1016\/j.jocn.2005.08.012","journal-title":"J Clin Neurosci"},{"issue":"5","key":"2091_CR248","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1212\/wnl.59.5.688","volume":"59","author":"AB Rao","year":"2002","unstructured":"Rao AB, Richert N, Howard T, Lewis BK, Bash CN, McFarland HF et al (2002) Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFN\u03b2-1b. Neurology 59(5):688\u2013694. https:\/\/doi.org\/10.1212\/wnl.59.5.688","journal-title":"Neurology"},{"issue":"1","key":"2091_CR249","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.nlm.2005.12.009","volume":"86","author":"ES Brown","year":"2006","unstructured":"Brown ES, Beard L, Frol AB, Rush AJ (2006) Effect of two prednisone exposures on mood and declarative memory. Neurobiol Learn Mem 86(1):28\u201334. https:\/\/doi.org\/10.1016\/j.nlm.2005.12.009","journal-title":"Neurobiol Learn Mem"},{"issue":"4","key":"2091_CR250","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/0091-6749(92)90449-C","volume":"89","author":"W Spiegel","year":"1992","unstructured":"Spiegel W, McGeady SJ, Mansmann HC (1992) Cerebral cortical atrophy and central nervous system (CNS) symptoms in a steroid-treated child with asthma. J Allergy Clin Immunol 89(4):918\u2013919","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2091_CR251","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1046\/j.1460-9568.2003.02542.x","volume":"17","author":"DJ de Quervain","year":"2003","unstructured":"de Quervain DJ, Henke K, Aerni A, Treyer V, McGaugh JL, Berthold T et al (2003) Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur J Neurosci 17(6):1296\u20131302. https:\/\/doi.org\/10.1046\/j.1460-9568.2003.02542.x","journal-title":"Eur J Neurosci"},{"issue":"10","key":"2091_CR252","first-page":"3251","volume":"82","author":"MJ De Leon","year":"1997","unstructured":"De Leon MJ, McRae T, Rusinek H, Convit A, De Santi S, Tarshish C et al (1997) Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer\u2019s disease. J Clin Endocrinol Metab 82(10):3251\u20133259","journal-title":"J Clin Endocrinol Metab"},{"key":"2091_CR253","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0920-9964(01)00219-5","volume":"56","author":"R Ganguli","year":"2002","unstructured":"Ganguli R, Singh A, Brar J, Carter C, Mintun M (2002) Hydrocortisone induced regional cerebral activity changes in schizophrenia: a PET scan stud. Schizophr Res 56:241\u2013247","journal-title":"Schizophr Res"},{"key":"2091_CR254","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.bbr.2018.06.024","volume":"359","author":"J Fleischer","year":"2019","unstructured":"Fleischer J, Metz S, Dusenberg M, Grimm S, Golde S, Roepke S et al (2019) Neural correlates of glucocorticoids effects on autobiographical memory retrieval in healthy women. Behav Brain Res 359:895\u2013902. https:\/\/doi.org\/10.1016\/j.bbr.2018.06.024","journal-title":"Behav Brain Res"},{"issue":"1","key":"2091_CR255","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1111\/ejn.14355","volume":"50","author":"EW Prouty","year":"2019","unstructured":"Prouty EW, Chandler DJ, Gao WJ, Waterhouse BD (2019) Selective vulnerability of dorsal raphe-medial prefrontal cortex projection neurons to corticosterone-induced hypofunction. Eur J Neurosci 50(1):1712\u20131726. https:\/\/doi.org\/10.1111\/ejn.14355","journal-title":"Eur J Neurosci"},{"issue":"3","key":"2091_CR256","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1037\/\/0735-7044.113.3.420","volume":"113","author":"SJ Lupien","year":"1999","unstructured":"Lupien SJ, Gillin CJ, Hauger RL (1999) Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans. Behav Neurosci 113(3):420\u2013430. https:\/\/doi.org\/10.1037\/\/0735-7044.113.3.420","journal-title":"Behav Neurosci"},{"issue":"6","key":"2091_CR257","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1523\/JNEUROSCI.4664-03.2004","volume":"24","author":"B Roozendaal","year":"2004","unstructured":"Roozendaal B, McReynolds JR, McGaugh JL (2004) The basolateral amygdala interacts with the medial prefrontal cortex in regulating glucocorticoid effects on working memory impairment. J Neurosci 24(6):1385\u20131392. https:\/\/doi.org\/10.1523\/JNEUROSCI.4664-03.2004","journal-title":"J Neurosci"},{"issue":"4","key":"2091_CR258","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/01.pra.0000432601.09514.12","volume":"19","author":"KD Young","year":"2013","unstructured":"Young KD, Preskorn SH (2013) Neuroscientific basis of corticosteroid-induced changes in human cognitive and emotional processing: implications for affective illness. J Psychiatr Pract 19(4):309\u2013315. https:\/\/doi.org\/10.1097\/01.pra.0000432601.09514.12","journal-title":"J Psychiatr Pract"},{"issue":"9","key":"2091_CR259","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00702-010-0441-4","volume":"117","author":"K Wuppen","year":"2010","unstructured":"Wuppen K, Oesterle D, Lewicka S, Kopitz J, Plaschke K (2010) A subchronic application period of glucocorticoids leads to rat cognitive dysfunction whereas physostigmine induces a mild neuroprotection. J Neural Transm (Vienna) 117(9):1055\u20131065. https:\/\/doi.org\/10.1007\/s00702-010-0441-4","journal-title":"J Neural Transm (Vienna)"},{"key":"2091_CR260","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s002130051057","volume":"145","author":"AH Young","year":"1999","unstructured":"Young AH, Sahakian BJ, Robbins TW, Cowen PJ (1999) The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology 145:260\u2013266","journal-title":"Psychopharmacology"},{"issue":"5","key":"2091_CR261","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1037\/0735-7044.115.5.1002","volume":"115","author":"OT Wolf","year":"2001","unstructured":"Wolf OT, Convit A, McHugh PF, Kandil E, Thorn EL, De Santi S et al (2001) Cortisol differentially affects memory in young and elderly men. Behav Neurosci 115(5):1002\u20131011. https:\/\/doi.org\/10.1037\/0735-7044.115.5.1002","journal-title":"Behav Neurosci"},{"issue":"5","key":"2091_CR262","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1440-1819.2009.02005.x","volume":"63","author":"P Fietta","year":"2009","unstructured":"Fietta P, Fietta P, Delsante G (2009) Central nervous system effects of natural and synthetic glucocorticoids. Psychiatry Clin Neurosci 63(5):613\u2013622. https:\/\/doi.org\/10.1111\/j.1440-1819.2009.02005.x","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"2091_CR263","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1176\/appi.ajp.2011.11071009","volume":"169","author":"L Fardet","year":"2012","unstructured":"Fardet L, Petersen I, Nazareth I (2012) Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry 169(5):491\u2013497. https:\/\/doi.org\/10.1176\/appi.ajp.2011.11071009","journal-title":"Am J Psychiatry"},{"issue":"2","key":"2091_CR264","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/8755122520978534","volume":"37","author":"G Huynh","year":"2021","unstructured":"Huynh G, Reinert JP (2021) Pharmacological management of steroid-induced psychosis: a review of patient cases. J Pharm Technol 37(2):120\u2013126. https:\/\/doi.org\/10.1177\/8755122520978534","journal-title":"J Pharm Technol"},{"issue":"5","key":"2091_CR265","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1089\/cap.2018.0017","volume":"28","author":"GE Hodgins","year":"2018","unstructured":"Hodgins GE, Saltz SB, Gibbs EP, Gonzalez R, Regan J, Nemeroff C (2018) Steroid-induced psychosis in the pediatric population: a new case and review of the literature. J Child Adolesc Psychopharmacol 28(5):354\u2013359. https:\/\/doi.org\/10.1089\/cap.2018.0017","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1\u20133","key":"2091_CR266","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0960-0760(91)90171-z","volume":"40","author":"D Filipini","year":"1991","unstructured":"Filipini D, Gijsbers K, Birmingham MK, Dubrovsky B (1991) Effects of adrenal steroids and their reduced metabolites on hippocampal long-term potentiation. J Steroid Biochem Mol Biol 40(1\u20133):87\u201392. https:\/\/doi.org\/10.1016\/0960-0760(91)90171-z","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2091_CR267","unstructured":"Program TBCDS (1978) Acute adverse reactions to prednisone in relation to dosage"},{"issue":"1","key":"2091_CR268","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0306-4530(95)00031-3","volume":"21","author":"D Naber","year":"1996","unstructured":"Naber D, Sand P, Heigl B (1996) Psychopathological and neuropsychological effects of 8-days\u2019 corticosteroid treatment. A prospective study. Psychoneuroendocrinology 21(1):25\u201331","journal-title":"Psychoneuroendocrinology"},{"key":"2091_CR269","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1212\/01.wnl.0000229924.76258.c1","volume":"67","author":"CI Prodan","year":"2006","unstructured":"Prodan CI, Monnot M, Ross ED, Coleman AE (2006) Reversible dementia with parkinsonian features associated with budesonide use. Neurology 67:723","journal-title":"Neurology"},{"issue":"5","key":"2091_CR270","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1037\/a0024764.supp","volume":"125","author":"K Young","year":"2011","unstructured":"Young K, Drevets WC, Schulkin J, Erickson K (2011) Supplemental material for dose-dependent effects of hydrocortisone infusion on autobiographical memory recall. Behav Neurosci 125(5):735\u2013741. https:\/\/doi.org\/10.1037\/a0024764.supp","journal-title":"Behav Neurosci"},{"issue":"1","key":"2091_CR271","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00004714-200202000-00009","volume":"22","author":"ES Brown","year":"2002","unstructured":"Brown ES, Suppes T, Khan DA, Carmody TJ III (2002) Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol 22(1):55\u201361","journal-title":"J Clin Psychopharmacol"},{"key":"2091_CR272","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/archpsyc.1990.01810220079010","volume":"47","author":"OM Wolkowitz","year":"1990","unstructured":"Wolkowitz OM, Rubinow D, Doran AR, Breier A, Berrettini WH, Kling MA et al (1990) Prednisone effects on neurochemistry and behavior. Arch Gen Psychiatry 47:963\u2013968","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"2091_CR273","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.nlm.2004.09.001","volume":"83","author":"S Kuhlmann","year":"2005","unstructured":"Kuhlmann S, Kirschbaum C, Wolf OT (2005) Effects of oral cortisol treatment in healthy young women on memory retrieval of negative and neutral words. Neurobiol Learn Mem 83(2):158\u2013162. https:\/\/doi.org\/10.1016\/j.nlm.2004.09.001","journal-title":"Neurobiol Learn Mem"},{"issue":"9","key":"2091_CR274","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.psyneuen.2013.01.009","volume":"38","author":"HJ van Marle","year":"2013","unstructured":"van Marle HJ, Hermans EJ, Qin S, Overeem S, Fernandez G (2013) The effect of exogenous cortisol during sleep on the behavioral and neural correlates of emotional memory consolidation in humans. Psychoneuroendocrinology 38(9):1639\u20131649. https:\/\/doi.org\/10.1016\/j.psyneuen.2013.01.009","journal-title":"Psychoneuroendocrinology"},{"key":"2091_CR275","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0306-4530(99)00007-4","volume":"24","author":"LA Schmidt","year":"1999","unstructured":"Schmidt LA, Fox NA, Goldberg MC, Smith CG, Schulkin J (1999) Effects of acute prednisone administration on memory, attention and emotion in healthy human adults. Psychoneuroendocrinology 24:461\u2013483","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"2091_CR276","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biopsycho.2010.10.001","volume":"86","author":"VA Taylor","year":"2011","unstructured":"Taylor VA, Ellenbogen MA, Washburn D, Joober R (2011) The effects of glucocorticoids on the inhibition of emotional information: a dose-response study. Biol Psychol 86(1):17\u201325. https:\/\/doi.org\/10.1016\/j.biopsycho.2010.10.001","journal-title":"Biol Psychol"},{"issue":"2","key":"2091_CR277","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1530\/eje.1.01953","volume":"153","author":"A Bhattacharyya","year":"2005","unstructured":"Bhattacharyya A, Kaushal K, Tymms DJ, Davis JR (2005) Steroid withdrawal syndrome after successful treatment of Cushing\u2019s syndrome: a reminder. Eur J Endocrinol 153(2):207\u2013210. https:\/\/doi.org\/10.1530\/eje.1.01953","journal-title":"Eur J Endocrinol"},{"key":"2091_CR278","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000804","author":"V Theiler-Schwetz","year":"2023","unstructured":"Theiler-Schwetz V, Prete A (2023) Glucocorticoid withdrawal syndrome: what to expect and how to manage. Curr Opin Endocrinol Diabetes Obes. https:\/\/doi.org\/10.1097\/MED.0000000000000804","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"2091_CR279","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO et al (2015) Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807\u20132831. https:\/\/doi.org\/10.1210\/jc.2015-1818","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2091_CR280","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1210\/er.2001-0014","volume":"24","author":"Z Hochberg","year":"2003","unstructured":"Hochberg Z, Pacak K, Chrousos GP (2003) Endocrine withdrawal syndromes. Endocr Rev 24(4):523\u2013538. https:\/\/doi.org\/10.1210\/er.2001-0014","journal-title":"Endocr Rev"},{"issue":"8","key":"2091_CR281","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1210\/jc.2018-00529","volume":"103","author":"R Pofi","year":"2018","unstructured":"Pofi R, Feliciano C, Sbardella E, Argese N, Woods CP, Grossman AB et al (2018) The short synacthen (corticotropin) test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function. J Clin Endocrinol Metab 103(8):3050\u20133059. https:\/\/doi.org\/10.1210\/jc.2018-00529","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2091_CR282","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1530\/EJE-20-1199","volume":"184","author":"K Laugesen","year":"2021","unstructured":"Laugesen K, Broersen LHA, Hansen SB, Dekkers OM, Sorensen HT, Jorgensen JOL (2021) Management of endocrine disease: glucocorticoid-induced adrenal insufficiency: replace while we wait for evidence? Eur J Endocrinol 184(4):R111\u2013R122. https:\/\/doi.org\/10.1530\/EJE-20-1199","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2091_CR283","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/s0889-8529(02)00008-7","volume":"31","author":"B Richter","year":"2002","unstructured":"Richter B, Neises G, Clar C (2002) Glucocorticoid withdrawal schemes in chronic medical disorders. A systematic review. Endocrinol Metab Clin North Am 31(3):751\u2013778. https:\/\/doi.org\/10.1016\/s0889-8529(02)00008-7","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"2091_CR284","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11102-022-01218-y","volume":"25","author":"X He","year":"2022","unstructured":"He X, Findling JW, Auchus RJ (2022) Glucocorticoid withdrawal syndrome following treatment of endogenous Cushing syndrome. Pituitary 25(3):393\u2013403. https:\/\/doi.org\/10.1007\/s11102-022-01218-y","journal-title":"Pituitary"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02091-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02091-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02091-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T22:16:18Z","timestamp":1695334578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02091-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":284,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["2091"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02091-7","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]},"assertion":[{"value":"14 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study does not involve human participants and\/or animals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human participants or animal rights"}}]}}